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ABSTRACT 
 This dissertation investigated measures of pharyngeal residue as seen on flexible 
endoscopic evaluation of swallowing (FEES). Research in this area of deglutology has 
been stalled due to measurement problems. The particular aims of this project were to 
compare visual analog scale ratings to categorical ratings of residue on FEES, and to 
investigate various measurement aspects.  
 Methods: Speech language pathologists were asked to rate residue from 81 
swallows on FEES that demonstrated a wide range of residue severity for thin liquid, 
applesauce, and cracker boluses. A total of 33 clinicians rated the amount of residue at 
the time point after the first swallow, twice in a randomized fashion: the first time on a 
visual analog scale (VAS) and the second time categorically on a five point Likert scale. 
The results were analyzed for (1) inter/intra-rater agreement, (2) correlations between 
ratings and residue severity for each rating method, and (3) clusters of ratings to better 
define the scales and their clinical significance. A total of 2,673 VAS ratings and 2,673 
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categorical ratings were collected.  
 Results: (1) Both inter- and intra-rater reliability met acceptable levels of 
agreement, although intra-rater reliability on VAS ratings were slightly higher (rc=0.8–
0.9) than categorical ratings (k=0.7–0.8). Expert ratings were not significantly different 
from other clinicians’ ratings for any severity of any of the 3 boluses. (2) Residue ratings 
fit best on a curvilinear model; a quadratic fit of the data significantly improved the r2 
values for each bolus type. (3) An increased residue amount, rated on either the VAS or 
categorical scale, was significantly associated with worse penetration-aspiration scale 
scores, but no significant relationship was found between the two methods of residue 
ratings and measures of quality of life or diet. Novel computerized methods are proposed 
for future measurement pursuits. 
 Conclusion: The results of this dissertation suggest that residue is best measured 
on a scale with unequal intervals, and clinicians can be reliable in rating overall amount 
of residue on FEES after the first swallow. Novel computerized measurement approaches 
are useful building blocks for future research. It is hoped that with better measurement 
will come better understanding of residue, its risks, and consequences. 
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CHAPTER ONE 
The Problem of Pharyngeal Residue 
Abstract 
This chapter defines pharyngeal residue and its consequences. In the first section, a 
conceptual framework is presented as a background to outline the immediate and long-
term outcomes of residue and swallowing problems, in general. A framework is sorely 
needed to integrate residue into the medical schema of dysphagia and highlight its 
consequences. In the second section, the chapter highlights the clinical presentation of 
residue: residue and aspiration, location of residue, residue and quality of life and diet, 
and clinician impressions of residue. The findings of several papers and pilot projects are 
presented to feature what has been studied in the field thus far and how these findings set 
the stage for the main results of the dissertation work in Chapters 4 and 5. 
 
1.1 What is Pharyngeal Residue and Its Consequences? 
 Eating and drinking are pleasurable and necessary parts of life. Not only is the act 
of swallowing vital for maintaining nutrition, but almost all social events, traditions, and 
holidays involve food and drinks. The ease of swallowing is largely taken for granted by 
the healthy population who do not think twice when eating or drinking. Yet for someone 
with a swallowing problem, or dysphagia, every bite or sip comes with fear, anxiety, and 
embarrassment.  
 One potential outcome of a swallowing problem is residue: food or liquid that is 
not cleared through the throat. Residue is what remains after the swallow. Residue can 
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occur in the oral cavity and in the pharynx. Patients who experience residue often report 
that, “food sticks” or “pills don’t go down,” while pointing to the throat. Residue can be 
suspected via patient report but is more accurately documented by instrumental 
evaluations such as a flexible endoscopic evaluation of swallowing (FEES) or a Modified 
Barium Swallow evaluation (MBS) (Figure 1). These instrumental evaluations use video 
imaging via endoscopy (on FEES) or videofluoroscopy (on MBS) to visualize the 
swallow mechanism and any possible dysfunction including residue, seen in Figure 1B. 
(A)           (B) 
     
Figure 1. Images from a simultaneous MBS/FEES immediately after (A) a normal swallow 
showing no residue and (B) an abnormal swallow demonstrating severe amounts of residue. 
 Residue can lead to devastating consequences such as choking, increased risk for 
aspiration, malnutrition, and decreased quality of life (Eisenhuber et al., 2002; Van der 
Burg et al., 2013; McHorney et al., 2002; Hunter et al., 2013). Despite these outcomes, 
residue is not a well-recognized or established symptom of dysphagia. Aspiration, on the 
other hand, is arguably the most recognized outcome of dysphagia. Aspiration is the 
passage of any food or liquid bolus below the level of the true vocal folds and into the 
airway. Many medical professionals often dichotomize the results of swallowing 
evaluations into two groups: ‘passed’ (no aspiration occurred) or ‘did not pass’ 
(aspiration occurred). However, for specialists in the field of deglutology, categorizing 
No Residue Residue 
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outcomes as “aspiration/no aspiration” does not fully capture the dysphagia, especially if 
outcomes other than aspiration occurred. Residue is a possible outcome that is not often 
addressed. Reasons why residue is generally not considered a valuable outcome may be, 
one, difficulty measuring and interpreting it, two, an indirect relationship to more serious 
consequences like pneumonia (see Figure 2), and three, a lack of recognition or disregard.  
 There is no established theoretical framework describing the importance of 
residue in the context of the broader picture of dysphagia. A framework is a necessary 
first step in measuring any entity and is sorely needed to integrate residue into the 
medical schema of dysphagia and highlight its consequences.  
1.1a. A Conceptual Framework 
 Clarification of the relationship between the immediate and long-term outcomes 
of residue would help elucidate where it stands as a construct within the larger medical 
schema of dysphagia. For example, how does residue lead to long-term outcomes? In 
response, this dissertation is proposing a conceptual framework as an important backdrop 
to the research investigation. This was a necessary first step because the literature is 
missing an all-encompassing framework. The conceptual framework depicted in Figure 2 
aims to create a model of swallowing problems and their outcomes with specific attention 
to how residue fits into the schema. The framework was inspired by Martino and 
colleagues (2009), who established salient themes for medical outcomes of dysphagia in 
their work based in qualitative grounded theory. Their research identified 3 medical 
outcomes of dysphagia: pulmonary, nutritional, and psychological outcomes. Previously, 
only psychosocial and clinical outcomes like coughing and length of time for eating were 
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put forth as salient outcomes in tools such as the MD Anderson Dysphagia Inventory 
(Chen et al., 2001) and the Swallowing Quality of Life and Swallowing Quality of Care 
(McHorney et al., 2000; McHorney et al, 2002; McHorney et al., 2006). Other 
assessments have been created to assess the impact of dysphagia on quality of life, but 
with specific purposes such as patient-reported symptoms that neglect medical outcomes 
(Silbergleit et al., 2012) or population-specific models (Clavé & Shaker, 2015; Ortega, 
Cabre, & Clavé, 2015).  
 To survey the literature, 13 databases were queried with search terms to capture 
any studies related to deglutition and medical outcomes for all populations who may 
experience dysphagia. Then, a framework was created from the findings from extant 
literature and from the opinions of a research lab specializing in deglutology. Next, a 
group of 12 experts (well-recognized leaders with more than 10 years experience who 
hold a doctorate in the field of speech language pathology) from across the United States 
were surveyed. They completed a structured questionnaire to review and edit the 
proposed conceptual framework. Figure 2 demonstrates the proposed model. 
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Figure 2. A proposed concept map of dysphagia as a means to incorporate residue into a 
framework. 
 At the top of Figure 2, yellow boxes indicate the various etiologies that could 
cause a swallowing problem. They can occur in isolation but more frequently occur in 
close combination with one another. As a result of the various etiologies, a swallowing 
problem will have an immediate result including one or a combination of consequences 
highlighted in the blue box. Here, it should be emphasized that residue, esophageal 
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reflux, and delay/mistiming/fatigue may occur independently as an immediate result or 
may subsequently lead to penetration and/or aspiration. Alternatively, it is possible for 
penetration/aspiration to occur without residue, for example if aspiration occurred before 
or during the swallow. The complex relationship of the immediate results warrants such 
clarification to assist in critical analysis of the dysphagia and how to best develop 
appropriate treatment goals or answer research questions. 
 Perhaps the most important aspect of the proposed conceptual framework is the 
potential long-term outcome box, outlined in light blue at the bottom of Figure 2. The 
long-term outcomes imply the consequences beyond the immediate events. Here, 5 broad 
long-term outcomes are proposed in isolation or combination with one another, 
expanding on the work done by Martino and colleagues (2009).  
 Social Outcomes 
 A reduced ability to eat and drink is most likely going to result in changes in 
activities/events, interference with family and friends, and interference with work. 
Problems with social functioning were the amongst the top four primary contributors to 
dysphagia-specific quality of life factors (McHorney et al., 2002): “I do not go out to eat 
because of my swallowing problem,” “Social gatherings are not enjoyable,” and “My 
usual activities have changed.” Many people who experience residue as part of their 
swallowing problem report avoidance of social gatherings because they have to “cough 
up” the food that gets stuck. Therefore, identifying social factors as potential long term 
outcomes of residue is a useful strategy to flag patients who may be at risk for outcomes 
like interference with work or family disruption. The work by McHorney and colleagues 
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(2002) brought to light the high impact of swallowing problems on social functioning and 
the strong (and significant) correlation between social function problems from dysphagia 
and psychological outcomes. 
 Psychological Outcomes 
 A second and closely-related outcome is psychological outcomes of dysphagia, 
salient in both medical and patient-reported outcomes (Martino et al., 2009; Silbergleit et 
al., 2011). Based on the literature, patients with dysphagia have reported depression, 
anxiety, embarrassment, loss of control, frustration, and vulnerability. These feelings 
could result from any of the symptoms of dysphagia, including residue. Residue gives a 
patient the pesky and uncomfortable feeling of some food or liquid left behind, resulting 
in lowered quality of life (Chen et al., 2009; van der Berg et al., 2013). In fact, patients 
considered psychological outcomes to outweigh other health outcomes like dehydration 
and choking (Martino et al., 2009). The research done by McHorney et al. (2002) found 
that “food sticking in throat” (suggestive of residue) was one of the top 5 complaints 
amongst 386 patients with dysphagia from various etiologies. Their work confirmed via 
factor analysis that psychological outcomes such as feelings of burden and fear were 
amongst the top contributors to dysphagia-related reduction in quality of life. Further, the 
psychological domains were weighted more than other outcomes such as eating duration 
or eating desire. Considering the impact of dysphagia (including residue) on mental 
health problems, clinicians should consider the psychological domain as a pertinent 
component of evaluation and treatment. 
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 Deconditioning/Disuse of Swallow 
 Frequently, a swallowing problem leads to weakness, fatigue, and reduced 
alertness. This is represented in the outcome labeled “Deconditioning/Disuse of 
Swallow.” For example, a swallowing problem may lead to generalized deconditioning 
and weakness of the body (due to malnutrition), which leads to even more swallowing 
problems, outlined by the large black arrow representing the cyclical nature of poor 
outcomes of dysphagia. The dangerous cycle of progressively worsening dysphagia 
should indeed be emphasized to identify patients in need of intervention and therapy. 
Deconditioning (weakness) can be a distinct outcome but almost always will go hand-in-
hand with other outcomes such as nutritional/metabolic outcomes, described below. 
 Nutritional/Metabolic Outcomes 
 Individuals with dysphagia are at high risk for malnutrition and dehydration (Lin 
et al., 2005; Foley et al., 2009; List et al., 1990; Martino et al., 2005), usually resulting 
from food or liquid avoidance or the need for non-oral feeding. Alternatively, patients 
with dysphagia have lower eating desire (McHorney et al., 2002). Patients on a restricted 
diet due to dysphagia precautions face a narrower choice of food options that can be 
profoundly limiting with orders like ‘puréed solids only.’ Remarks like, “I don’t enjoy 
eating anymore” and “Most days, I don’t care if I eat or not” were amongst the top 
contributors to quality of life factors (McHorney et al., 2002). In Martino’s work, a 
common theme was a concern that malnutrition would reduce the patient’s capacity to 
fight the disease: “When they’re eating regular meals, their strength or their general 
health is alright, but if it got to the point where they couldn’t use solids, [then] liquids 
  
9
would be more difficult to try to get the right nutrition for them” (Martino et al. 2009, p. 
520). 
 In another example, patients may avoid the recommended nectar-thick liquids due 
to distaste, but end up severely dehydrated (Kaneoka et al., 2016). Dehydration manifests 
in many different ways, ranging from xerostomia, dry skin, and fatigue, to confusion and 
thickening of secretions. In one study, clinicians and patients viewed dehydration as more 
serious than malnutrition (Martino et al., 2009). Not only are symptoms of dehydration 
bothersome and potentially dangerous, but they can perpetuate in a cyclical fashion. 
Patients with dysphagia may be dehydrated, and then due to dry mouth or secretions, for 
example, their dysphagia is worsened. Thus, there is an insidious feedback loop of long-
term outcomes contributing to the dysphagia as its own cause.  
 Pulmonary Outcomes 
 Finally, pulmonary outcomes are generally considered the most concerning 
consequence of a swallowing problem. Pulmonary outcomes include lung infection 
(aspiration pneumonia) that can lead to bronchiectasis, sepsis, and/or whole body 
involvement. Residue can be inhaled into the trachea post-swallow (Ney, Weiss, & 
Robbins, 2009) and cause aspiration pneumonia. Ample work has shown that residue 
increases the risk of aspiration (Perlman et al., 1992; 1994; Han et al., 2001; Eisenhuber 
et al., 2002; Logemann, 1998). This is concerning given that over 50% of a sample 
patients with dysphagia demonstrated various levels of pharyngeal residue (Perlman et 
al., 1992; 1994; Kuhlemeier et al., 2001). There are several distinct characteristics of this 
particular outcome that must be discussed.  
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 One, as put forth in Martino et al.’s work (2009), clinicians tend to focus on 
pulmonary outcomes as the most direct threat to patient mortality: “You’re more 
concerned about pulmonary than nutritional status and hydration and all that other stuff. 
I’m sorry, tough luck at this point. You know you try and keep all the things in line. I 
mean, if you can, you include the psychological stuff, you definitely do, but if it’s between 
that and pulmonary, pulmonary wins’’ (Martino et al. 2009, p. 523). Aspiration 
pneumonia can lead to chronic lung congestion, lung collapse, sepsis, and even death. 
The risks of aspiration pneumonia are thoroughly documented in the literature especially 
in populations such as stroke patients and elderly. In a landmark study, Langmore and 
colleagues (1988) identified several predictors of aspiration pneumonia in the large 
cohort of 189 subjects from an outpatient clinic. The most significant predictors of 
aspiration pneumonia were dependence for feeding, multiple medical diagnoses, a current 
smoker, tube feeding before the pneumonia, dependence for oral care, number of decayed 
teeth, and number of medication. Interestingly, none of the factors directly related to 
dysphagia emerged as significant. To cite the authors, “dysphagia and aspiration may not 
be critical risk factors in a person who is medically stable, has a clean, healthy mouth, 
and/or is independent for daily activities” (Langmore et al., 1998, p. 76). Thus, 
pulmonary outcomes are only one of the important long-term outcomes of a swallowing 
problem and this specific outcome should not be treated as more significant than any 
other.  
 Two, pulmonary outcomes can only result from the immediate result of 
penetration/aspiration and no other immediate result. That is, a pulmonary outcome 
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cannot occur from an event such as nasal emission. Penetration and aspiration are 
mediator variables in the proposed causal pathway between a swallowing problem and 
long-term complications. Phrased differently, penetration and subsequent aspiration are 
required events for a pulmonary complication.  
 Three, the framework proposes that pulmonary outcomes have a unidirectional 
relationship to the other long-term outcomes. For instance, a pulmonary outcome like 
coughing and choking could lead to psychological outcomes but the psychological 
outcomes could not lead to pulmonary outcomes. In this sense, pulmonary outcomes are a 
distinct physiologic by-product of a swallowing problem. What are often neglected are 
the other outcomes: social, psychological, deconditioning, and nutritional. 
 
1.2. Clinical Presentation of Residue 
 This section highlights the clinical presentation of residue in several studies done 
as preliminary work towards this dissertation. Residue is a useful measure of 
pathophysiologic dysfunction; it can indicate a dysfunctional part of a swallow, in a 
different way than aspiration. Residue tends to collect in the area of dysfunction. For 
example, residue in the valleculae is indicative of reduced base of tongue retraction 
toward the posterior pharyngeal wall or incomplete epiglottic retroflexion (Dejaeger et 
al., 1997; Ono et al., 2007). Residue at the posterior cricoid region suggests reduced 
opening of the upper esophageal sphincter (Logemann et al., 1989). It may also collect on 
only one side of the pharynx, showing unilateral weakness. In other presentations, residue 
may present diffusely in multiple locations, in which case a combination of the following 
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might be suspected: reduced strength of pharyngeal contraction, weak tongue pressure, 
reduced laryngeal elevation (Dejaeger et al., 1997; Pauloski et al., 2009; Teguh et al., 
2008; Eisenhuber et al., 2002; Batth et al., 2012), and reduced hyolaryngeal excursion 
(McCullough et al., 2012).  
 Although small amounts of pharyngeal residue can be the result of the normal 
aging process (Perlman et al., 1994), Kelly et al. (2008) found that substantial amounts of 
residue in any population is abnormal and most likely indicates a swallowing problem. 
Some of the preliminary work done as part of this dissertation investigated variables such 
as: timing of aspiration in relationship to residue, location of residue, residue’s 
relationship to quality of life, and clinician impressions of residue. 
1.2a. Timing of Aspiration in Relationship to Residue 
 Residue can be operationally defined by a timing variable: any remnant of bolus 
that remains after the swallow. An event that occurs before the swallow is likely due to a 
different problem altogether, such as poor timing and reduced control. Therefore, when 
aspiration occurs after the swallow, it is most likely due to residue. One way to identify if 
residue caused aspiration would be to indicate when the aspiration occurred: before, 
during, and/or after the swallow.  
 As a preliminary component to this body of work, a study was performed that 
analyzed the relationship between residue and timing of aspiration in a sample of 168 
patients with head/neck cancer (HNC) (Langmore et al., 2015). On each patient’s MBS 
evaluation, the timing of penetration and aspiration was noted for the first trial of each 
standardized bolus. On all consistencies, there was a significantly higher number of 
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aspiration occurrences after the swallow than before or during the swallow (p<0.05) 
(Figure 3). 
 
Figure 3. Frequency of aspiration before, during, and after the swallow on 3 different bolus 
types. 
 
 While aspiration is a crucial concern for all patients, the findings of this study 
argue that in HNC patients, aspiration occurs because of residue. Aspiration occurred 
more frequently after the swallow, making it a byproduct of the primary problem of 
residue. Residue, therefore, should be treated and accounted for as a primary symptom of 
dysphagia in this population. These results can likely be generalized to the HNC 
population as a whole, suggesting that residue should be considered a primary outcome of 
interest when evaluating dysphagia, and both aspiration and residue are equally 
problematic.  
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1.2b. Does Location of Residue Matter? 
 In another pilot study performed for this body of work, investigators explored 
residue on FEES, as rated in 3 zones (Pisegna, Kaneoka, & Langmore, 2016). This work 
addressed the question: Does location of residue matter? Previous studies have been in 
disagreement about which location poses the highest risk for aspiration. Some report that 
the valleculae is the most dangerous location for residue and others report the piriform 
sinuses are more dangerous (Han, Paik, & Park, 2001; Molfenter & Steele, 2013). 
However, these studies used videofluoroscopic videos, which give a different impression 
than FEES videos.  
 Using FEES videos allows for better bilateral assessment of residue and a better 
view of the pharyngeal and laryngeal swallowing structures. The visible anatomy was 
grouped in 3 zones defined from a previously published factor analysis that calculated 
factor loadings of 12 pharyngeal and laryngeal locations with residue across several bolus 
consistencies (Kaneoka et al., 2013). By grouping the highest factor loads, the authors 
reported that residue in the pharynx/larynx tended to occur in 3 neighborhoods, or 
“zones” (Figure 4A). One-hundred and twenty FEES videos of 3 uniform boluses (thin 
liquid, apple sauce, cracker) were rated independently by 2 raters for the 
presence/absence of >coating residue in each of the 3 zones.  
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 (A) (B) 
                                        
Figure 4 (A.) The 3 zones, or neighborhoods, where residue tends to collect in the pharynx 
and larynx (Kaneoka et al., 2013). (B.) Demonstration of residue in Zone 1 and Zone 2 
leading to penetration into Zone 3. 
 There were 29 penetration/aspiration events and 62% (18/29) occurred after the 
swallow, on residue. But from where was the residue entering into the laryngeal 
vestibule? From the 18 videos that showed aspiration after the swallow, 7 
penetration/aspiration events came from residue in Zone 2 (3 applesauce and 4 thin 
liquid), and 4 events happened on residue from Zone 1 (3 applesauce and 1 cracker) 
(Figure 4B; 2 events came from both locations and 5 were not visualized). This 
preliminary finding of a higher occurrence of aspiration on residue from Zone 2 (the 
piriform sinuses) is supported by a previous study (Han, Paik, & Park, 2001), but is in 
contrast to another finding that residue in the valleculae puts patients at higher aspiration 
risk than residue in the piriform sinuses (Han, Paik, & Park, 2001; Molfenter & Steele, 
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2013). Mixing videos of various consistencies could have been an influential factor 
driving the different findings. It is no surprise that thin liquid penetration events from 
Zone 2 were most frequent, given their tendency to flow to the lowest point in the 
pharynx. 
 The relationship between zones and residue severity was also investigated. For the 
21 instances of residue in Zones 1+2+3, the overall severity ratings ranged from mild to 
severe. There was a small and non-significant relationship between the severity ratings 
and PAS scores in this sample (r=0.29, p=0.19).  
 In sum, location of residue is an important factor to consider in determining 
aspiration risk although bolus consistency is another imperative consideration. In this 
sample, more instances of penetration/aspiration occurred on residue from Zone 2 than 
from residue in Zone 1. The presence of overall residue in zones was seemingly unrelated 
to overall residue severity, as diffuse residue in all 3 zones was sometimes rated overall 
as mild, while residue in only one zone sometimes received an overall severe rating. 
Further, overall residue severity was not strongly correlated with PAS scores. This 
finding highlights the great need for reliable and valid measurement of residue on FEES. 
Perhaps rating the presence of residue in high-risk zones rather than overall amount 
would be beneficial. Future work should continue to investigate residue severity and 
positioning of residue as it relates to aspiration risk.  
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1.2c. Residue in Relationship to Quality of Life and Diet  
in Head and Neck Cancer Patients 
 
 Another important facet of residue is its influence on quality of life and diet. As 
discussed in the conceptual framework, negative social outcomes (such as dislike for 
eating in front of other people) and negative nutritional outcomes (such as food 
restrictions and aversion) present as major barriers to people with dysphagia. This is 
especially meaningful in populations such as those with head/neck cancer (HNC), where 
dysphagia is a likely side effect in the wake of the cancer treatment (Hutcheson et al., 
2012). Therefore, an investigation was done to establish the role of dysphagia in a HNC 
group and their reported diet and quality of life (Meyer et al., 2016). 
 Data was taken from a multi-site randomized controlled trial (Langmore et al., 
2015). The subjects were 138 HNC patients who were greater than 3 months post-
completion of their cancer treatments who also had moderate to severe dysphagia. The 
percent of residue was estimated in intervals of 5% (ranging from 0–100%) as the 
subjective percent of the original bolus that remained in the pharynx (Logemann et al., 
2005). The clinicians completed a diet scale in accordance with patient-reported diet 
using the Performance Status Scale (PSS) (List et al., 1990), which asked about normalcy 
of diet and eating in pubic. The patients completed a quality of life scale, the Head Neck 
Cancer Inventory (HNCI) (Funk et al., 2003), which asked about eating enjoyment and 
social engagement. 
 Pharyngeal and oral residue demonstrated just as high correlations as PAS scores 
with the outcome measures. Figures 5A, 5B, and 5C demonstrate the adjusted 
correlations by the size of the circles. The green and red circles (pharyngeal and oral 
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residue) are similar sizes to the blue circles (PAS), highlighting the similar relationship of 
residue and PAS scores to quality of life and diet outcomes.  
(A)                                                                              (B) 
           
                                          (C) 
  
Figure 5 (A.) The correlations between 5mL thin liquid pharyngeal residue, oral residue, 
and penetration-aspiration scale scores with quality of life and diet ratings. (B.) The same 
correlations but for 5mL nectar residue. (C.) The same correlations but for 5mL pudding 
residue. 
 In this sample of patients with moderate to severe dysphagia, both residue and 
aspiration (PAS scores) correlated with diet and quality of life surveys. This is not 
surprising given that a patient’s quality of life and diet are determined in part by their 
attitude towards function and not medical outcomes like aspiration or pneumonia. The 
results emphasize that residue, an important component of swallowing function, had an 
independent effect on a patient’s eating enjoyment, social functioning, diet, and 
willingness to eat in public. What would be interesting is if these same results apply to 
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populations other than the HNC population and those with lesser dysphagia severity. This 
is one of the research questions of this dissertation, introduced in Chapter 3. 
1.2d. A Diagnostic Dilemma: Clinician Impressions of Residue 
 Another factor that has gone largely unmentioned is the influence of the clinician 
on ratings of residue. After all, the severity of residue is the perceptual opinion of the 
clinician. A recent study aimed to compare differences of residue severity between 
simultaneous MBS and FEES videos (Pisegna & Langmore, 2015). Fifty-five clinicians 
watched 4 videos edited from 2 simultaneous studies. The clinicians were not told the 
videos were simultaneous studies. They filled out a questionnaire that asked for various 
impressions including how they defined residue and their overall clinical impression of 
residue on a 5-point categorical scale. 
 Clinicians reported a variety of definitions and descriptors for residue. The 
majority (20.3%, n = 13) reported that they defined the amount of residue based on the 
percentage of a cavity or an area filled or covered by residue. Almost as many clinicians 
(18.8%, n = 12) reported using the percentage of ingested bolus remaining or left behind, 
and 17.2 % (n = 11) gave unclear definitions such as “trace.” Table 1 provides a 
summary of emergent themes across the clinicians’ definitions. 
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Table 1. Themes from open-ended responses to “How do you define pharyngeal residue?” *9 
responses contained two themes, thus the total of 64 from 55 responses. 
 Clinicians were also asked, “Overall, how much residue did you see?” The results 
of the global impression are shown in Figure 7.  The distribution of ratings was 
significantly different across the FEES and MBS ratings for both patients (χ2=20.05, 
p<0.0001). 
 
Figure 6. The number of clinicians who rated overall impression of pharyngeal residue in 
Patient 1’s FEES and MBS videos. *Significant discrepancies across the ratings scales 
between FEES and MBS categories at p<0.05. 
How to Rate Residue  
Definition Themes 
Number of 
Responses 
Relative 
Frequency (%) 
Percentage of a cavity filled or covered by residue 13 20.3% 
Percentage of bolus remaining or left behind 12 18.8% 
Not clearly defined 11 17.2% 
Clearing ability 7 10.9% 
Not answered 6 9.4% 
Potential for severity if that amount was aspirated 5 7.8% 
Presence on a number of structures/locations 5 7.8% 
Amount of residue seen in general (mild-severe) 2 3.1% 
Changing location, not stationary 2 3.1% 
A scale of 1–10 of how much fills the pharynx 1 1.6% 
Total 64* 100% 
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 Clinician ratings demonstrated a great range of severity, in one case from mild to 
severe on one video. This occurred for both MBS and FEES videos. It is concerning that 
clinicians interpreted the residue amount so differently. Such differences in 
interpretations likely occur in clinical practice everyday, putting patients at risk for 
varying diagnoses and treatment recommendations. Evidence is sparse regarding 
agreement of residue ratings. The few studies that have investigated the dilemma of 
rating residue relied on general agreement or consensus between expert judges as the 
‘gold standard’ to determine how much residue was actually present (Neubauer, 
Rademaker, Leder, 2015; Kaneoka et al., 2013). While consensus opinion is one way to 
estimate the amount of residue, it does not necessarily reflect the actual amount of 
residue present. This is because raters are judging the amount of residue by eye and not 
quantifying the amount precisely. The gold standard for rating residue on FEES remains 
elusive.  
 The findings of this study have implications for informing possible future scales 
that may attempt to rate parameters such as residue on FEES, MBS studies, or both. 
Chapters 4 and 5 discuss the findings of this dissertation, which examined reliability in a 
larger sample of clinicians, painting a broader picture about the implications of clinician 
agreement on residue ratings.  
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CHAPTER TWO 
The Problem of Residue Measurement on FEES 
Abstract 
This chapter features a review of previous literature describing scales to measure 
pharyngeal residue on Modified Barium Swallow (MBS) evaluations, scintigraphy, and 
flexible endoscopic evaluation of swallowing (FEES). The extensive review is provided 
to describe the measurement format of prior scales, the various definitions of residue, and 
other factors like timing of when to score. The extant scales, however, have not evaluated 
which form of measurement is best for residue. Thus, this chapter also proposes the 
desirable psychometric properties of residue as a preliminary way to determine an ideal 
measurement approach. The psychometric properties are discussed as a critical 
foundation of the novel dissertation work presented in Chapters 3, 4, and 5. 
2.1. Prior Attempts to “Make Measureable What Is Not So” 
 In the field of dysphagia, where measurement is an important calculation that has 
been incorporated into many diagnostic techniques, it is surprising that there are very few 
methods with published validity and reliability for rating pharyngeal residue on FEES. As 
put forth in Chapter 1, residue is an important factor in the lives of people with 
dysphagia. Diagnostic evaluations of swallowing should include measures of residue and 
the suspected clinical impact, along with prognosis of the dysphagia. However, the 
current measures of residue on FEES are grossly subjective and imprecise. This is where 
the field currently stands, halted. One of the over-arching goals of this dissertation work 
is to “measure what is measureable, and make measureable what is not so” (a quote by 
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Galileo Galilei introduced in the Concepts of Measurement course taught by Dr. Wendy 
Coster). 
 Many investigators have established multiple objective measures for MBS 
evaluations. In contrast, at the time of this writing, there is no known way to calculate 
precise measurements of residue on FEES. In the absence of a valid and reliable method 
of precision, most assessments on FEES are made subjectively. What is it, then, about 
endoscopy that makes measurement so difficult? One of the biggest limitations has been 
the inability to measure depth. Thus far, there has been no published method to estimate 
or calculate the depth of the anatomical cavities seen on endoscopy (Figure 7). 
 
 
 
 
 
Figure 7. A schema to represent the difficult-to-measure dimension of depth on endoscopy, 
such as the depth of the valleculae, laryngeal vestibule, and piriform sinuses. 
 A search of the literature was carried out to investigate how current scales have 
attempted to measure residue. The search returned over 16 different scales to measure 
residue on a MBS (see Table 2). Only 9 rating scales could be found for FEES, all of 
which were subjective or binary estimates. The best proposed measures for pharyngeal 
residue have been developed on MBS evaluations and are two-dimensional, estimating 
length and width. For example, Pearson and colleagues (2013) developed a scale for 
measuring residue on MBS evaluations by, one, determining the two-dimensional ratio of 
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residue in its anatomical cavity, and, two, scaling the ratio to the size of the patient via a 
referent of the cervical spine. In that methodology, there is a missing dimension of width, 
but that known limitation has not deterred the use of a semi-quantifiable method. It begs 
to reason, then, why is there not a method to measure residue in a similar way on FEES, 
which is also a two-dimensional view? 
 Another problem could be the required level of precision. Is it necessary to 
determine the precise amount of residue, or would a less precise method suffice, 
providing the same clinical information? In other words, how much accuracy is required? 
In the MBS literature, critical cut-off points have been developed for clinical 
significance. For example, Molfenter and Steele (2013) have determined that for the 
Normalized Residue Ratio Scale, a value of 0.09 in the valleculae is a significant cut 
point for aspiration risk on MBS evaluations. Park and colleagues (2014) also determined 
cutoff values of percent of the valleculae and piriform sinuses filled with residue in 
relationship to higher aspiration risk on MBS evaluations. There have been no 
comparable methods on FEES. 
 Table 2 outlines the thorough review of published methods for rating pharyngeal 
residue. The table lists MBS, scintigraphy, and FEES rating scales. Importantly, for the 
majority of the scales, the rating is perceptual (estimated ‘by eye’) and is either binary or 
ordinal in nature. Only three scales for rating residue on MBS evaluations use quantified 
computerized methods (Dyer et al., 2008; Pearson et al., 2013; Park et al., 2014). 
Furthermore, the scales for rating residue on FEES are much less robust and demonstrate 
a lack in technological advancement, with 0 scales involving computerized measurement. 
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There is clearly a need for further development of quantifiable scales for measuring 
residue, particularly on FEES. 
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Modified Barium Swallow (MBS) Evaluations 
Measurement 
Name 
Exam 
Type 
Rating Type, 
Definition, and 
Location 
Timing Reliability Notes 
Relevant 
Publications 
Pharyngeal 
Retention 
MBS 
Value (estimation 
by eye):  
Binary,  
Present/absent “After the 
swallow” using 
VHS 
videocassette 
slow motion for 
frame-by-frame 
analysis. 
Unclear:  
“Reliability tests on 
the item of retention 
resulted in a 100% 
level of agreement.”  
(p. 64) 
Binary rating further 
clarified in text as: 
1. No retention. 
2. Retention one or 
both of the  vallecular 
spaces after the 
swallow.   
3. Retention in one or 
both  of the piriform 
sinuses after the 
swallow.  
4. Diffuse pharyngeal 
retention, which is 
defined as retention in 
the  valleculae and in 
the piriform sinuses. 
Dejaeger et 
al., 1997 
Location: 
Valleculae, piriform 
sinuses 
Bolus  
Residue Scale  
(BRS) 
MBS 
Value (estimation 
by eye):  
Binary,  
Present/absent 
Unclear:  
“postswallow” 
Expert inter-rater 
ICC=0.78, intra-
rater average=0.972 
(n=4). 
 
Nonexpert inter-
rater = not reported, 
intra-rates 
average=0.835 
(n=6). 
(Rommel et al., 
2015) 
Scored 0–6 based on 
presence of residue in a 
certain location and 
number of locations: 
1. No residue. 
2. Residue in valleculae 
only (+2). 
3. Residue in posterior 
pharyngeal wall or 
piriform sinus (+3). 
4. Residue in valleculae 
and posterior 
pharyngeal wall or 
piriform sinus (+4). 
5. Residue in posterior 
Omari et al., 
2011 
 
Rommel et 
al., 2015 
Location: 
Valleculae, piriform 
sinuses  
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pharyngeal wall and 
piriform sinus (+5). 
6. Residue in 
valleculae, posterior 
pharyngeal wall, and 
piriform sinus (+6). 
 
Clearing swallows are 
described as subsequent 
swallows after the first 
swallow if the first 
swallow failed to clear 
the bolus. 
Bolus Stasis MBS 
Value (estimation 
by eye): 
Categorical, 
Mild stasis 
Moderate stasis 
Severe stasis 
“After the 
swallow or series 
of swallows 
executed with 
each bolus.” 
“Reliability tests 
performed on each 
variable resulted in high 
levels of agreement 
ranging from 100% on 
aspiration and 94% on 
reduced laryngeal 
elevation, to the lowest 
value of 70% for 
reduced hyoid elevation. 
All other values ranged 
from 82% to 88% 
agreement.” (p. 91) 
Vallecular and pyriform 
sinus stasis were 
considered present 
when barium remained 
in one or both of the 
spaces  
 
“Diffuse 
hypopharyngeal stasis” 
was considered present 
when barium remained 
in all 3 locations. 
Perlman, 
Booth, & 
Grayhack, 
1994  
Location:  
Valleculae, piriform 
sinuses, walls of 
hypopharynx 
Dysphagia 
Outcome and 
Severity Scale 
(DOSS) 
MBS 
Value (estimation 
by eye): 
Categorical with 
qualifiers,  
Mild 
Moderate  
Severe 
-and- 
Spontaneous or cued 
“After a swallow 
has been 
completed.”  
(p. 141) 
Interjudge reliability 
for overall DOSS 
score: exact match 
on 90% of cases. 
 
Intrajudge reliability 
for overall DOSS 
score: exact match 
on 93% of cases. 
7-item diet scale 
incorporating residue 
amount and ability to 
clear residue 
with/without cueing 
O'Neil et al., 
1999 
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re-swallow or 
strategy 
-and- 
Effectiveness of 
clearing attempts 
Location: 
Pharynx 
Residue MBS 
Value (estimation 
by eye): 
Categorical,  
0 – No residue 
1 – Coating, a line 
of barium on a 
structure  
2 – Pooling, an area 
larger than a line of 
barium on a 
structure 
Postswallow 
barium contrast 
residue was 
judged from the 
videofluoroscopi
c image when 
the hyoid bone 
returned to rest. 
“Reliability measures 
were not completed for 
this data set.” 
None. 
Hind et al., 
2001 
 
Robbins et 
al., 2007 
Location: 
Valleculae, posterior 
pharyngeal wall, 
pyriform sinuses, 
oral cavity, upper 
esophageal sphincter 
Measurement 
Tool for 
Swallow 
Impairment 
(MBSImp) 
MBS 
Value (estimation 
by eye): 
Categorical,  
0 – None 
1 – Trace (outline of 
coated structures) 
“…after the 
initial swallow 
and only after 
multiple 
swallows on the 
sequential liquid 
Trained to achieve 
exact match with 
lead author on at 
least 80% of the 
items (n=10 
clinicians). 
Defined as the amount 
of bolus material 
remaining in the 
pharynx. 
Diffuse residue was 
defined as the “>3 
areas.” 
Martin-Harris 
et al., 2008 
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2 – Collection 
(sufficient to extract 
or ‘scoop’) 
3 – Majority (more 
than half of original 
bolus) 
4 – Minimal/no 
clearance of bolus 
swallow task.” 
Location:  
Tongue base, 
 valleculae, 
 pharyngeal wall, 
aryepiglottic folds, 
pyriform sinuses,  
 
Functional 
Dysphagia 
Scale (FDS) 
MBS 
Value (estimation 
by eye): 
Categorical,  
0 – No residue 
1 – <10% of all 
width of valleculae 
or pyriform sinuses 
2 – >10–50% of 
width 
3 – >50% of width  
Unclear, not 
stated. 
“The Pearson’s r 
coefficients and 
ICCs for the total 
score of the 
functional dysphagia 
scale calculated 
from 20 patients, 
randomly sampled, 
were .79 and .79 
between tests, and 
.73 and .74 between 
examiners, 
respectively.” (p. 
679) 
 
Only width is 
considered, not 
height. The article 
also recorded a 
binary rating of 
yes/no for coating 
of the pharyngeal 
wall after repeated 
swallowing. 
Han et al., 
2001 
Location: 
Valleculae, pyriform 
sinuses 
Residue MBS 
Value (estimation 
by eye): 
Not indicated. 
Not reported.  Ryu et al., 
2012 
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Categorical,  
None – <10%,  
Small – 10–50% 
Large – >50%  
Location: 
Vallecular pouch, 
pyriform sinuses 
Pharyngeal 
retention 
MBS 
Value (estimation 
by eye): 
Categorical,  
Mild – <25%  
Moderate – 25–50% 
Severe – >50% 
height of 
valleculae/pyriform 
sinuses 
“After the first 
swallow of 
contrast 
material” on the 
thick-liquid 
bolus.  
Not reported. 
 
 
Residue was 
defined as residual 
material that 
exceeded a thin 
mucosal coating 
after swallowing.  
Anterior and lateral 
planes were used 
for analyses.  
Eisenhuber et 
al., 2002 
 
Location: 
Valleculae, pyriform 
sinuses 
Video-
fluoroscopic 
Dysphagia 
Scale (VDS) 
MBS 
Value (estimation 
by eye): 
Categorical (for 
valleculae and 
pyriforms),  
None 
<10% 
10–50% 
>50%  
Binary (for coating 
of pharyngeal wall),  
Yes, No 
Not stated. Not reported. 
Residue was 
defined as “% of 
the area of the 
vallecular or 
pyriform sinus in 
two-dimensional 
view” 
 
Han et al., 
2008 
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Location:  
Valleculae, piriform 
sinus, pharyngeal 
wall 
Oral Residue 
(ORES)  
and  
Pharyngeal 
Residue  
(PRES) 
MBS 
Value (estimation 
by eye):  
Continuous, 
0–100%, 
approximate percent 
of the original bolus 
that remains 
After the first 
swallow  
of the bolus 
Not reported. 
Calculated to create 
the Oropharyngeal 
Swallow Efficiency 
(OPSE) by dividing 
approximate 
percent of the bolus 
swallowed into the 
esophagus divided 
by oropharyngeal 
transit time 
Pauloski et 
al., 2002 
Location: 
Oral cavity, pharynx 
Maximum % 
of pharyngeal 
residue 
MBS 
Value (estimation 
by eye):  
Categorical, 
Minimal to no 
residue – <10%,  
Less than half 
residue – 10–49% 
Majority residue – 
50–90% 
Near complete 
residue – >90%  
“After initial 
swallow attempt 
of each bolus” 
“Intrarater reliability was 
excellent for both raters 
(weighted k=0.82–0.84). 
Agreement between the 
2 raters was almost 
perfect for efficiency 
(weighted k=0.81) and 
substantial for safety 
(weighted k=0.67). 
Interrater agreement on 
the summary DIGEST 
grade was substantial 
(weighted k=0.67).”  
(p. 3) 
Percentage is a 
proportion of how 
much of the bolus was 
swallowed (per 
personal 
correspondence with 
author). 
Pattern of residue 
across liquid, pudding, 
or cracker/cookie bolus 
types but depending on 
bolus, a different 
efficiency grade is 
assigned (0, no 
dysphagia – 4, life-
threatening), 
Hutcheson et 
al., 2016 
 
Location: 
Pharynx only 
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Valleculae 
Residue Ratio 
(VRR) 
MBS 
Value 
(computerized): 
Continuous,  
0–1 
“The 
radiographer 
stored stills of 
the valleculae 
after the 
swallow, 
indicated by the 
hyoid bone 
returning to its 
resting position 
following the 
test bolus.”  
 
Inter-rater reliability 
weighted k=0.73 
(n=5 on 80 still 
frames). 
 
Intra-rater reliability 
weighted k=0.85 
(n=5 on 20 repeated 
still frames). 
 
 
Size of residue (residue 
height X residue width) 
as a proportion of an 
individual’s valleculae 
size (valleculae height 
X valleculae width). 
Dyer, Leslie, 
& Drinnan, 
2008 
 
de Deus 
Chaves et al., 
2014 
Location: 
Valleculae 
Remnant area 
to total area, 
(R/T) ratios 
MBS 
Value 
(computerized):  
Continuous,  
0–1 
Not stated. 
 
 
“The ICC was 0.920 
in solid, 0.962 in 
soft, and 0.887 in 
liquid foods.” (n=2 
medical trainees)  
(p. 616) 
 
 
 
 
 
 
 
 
 
 
 
 
“Remnant area to total 
area (R/T) ratio is the 
proportion of residues 
of valleculae and 
pyriformis sinuses to 
their total spaces in 
solid/soft/liquid foods.”  
Park et al., 
2014 
Location:  
Valleculae, pyriform 
sinus 
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(pp. 614–615) 
Normalized 
Residue Ratio 
Scale (NRRS) 
MBS 
Value 
(computerized):  
Continuous,  
0–1 
“Residue was to 
be rated using 
the frame of 
lowest hyoid 
position 
following the 
initial swallow 
in the series.”  
“…kappa scores 
showed that residue 
scores did not 
achieve substantial 
agreement for the 
valleculae (k=0.33), 
while scores for 
piriform sinuses met 
our a priori criterion 
for agreement 
(k=0.66).”  
(p. 8) 
 
 
((A1/[A1 + A2]) X 
[(A1/N2) X 10] 
Pearson Jr. et 
al., 2013 
 
Stokely et al., 
2015 
 
Location:  
Valleculae, pyriform 
sinuses 
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Scintigraphy 
Measurement 
Name 
Exam 
Type 
Rating Variable 
Type, Definition, 
and Location 
Timing Reliability Notes 
Relevant 
Publications 
Pharyngeal 
Retention 
Scintigraphy 
Value 
(computerized): 
Continuous,  
0–100% of 
radioactive activity 
emitted from a 
radionuclide mixture 
detected by a 
scintillation 
(gamma) camera 
Immediately 
after the first 
swallow, and 
again after the 
clearing 
swallows.  
Radioactive 
counts averaged 
over six frames 
and referenced to 
the total time-
activity curve. 
 
“Test–retest 
reliability was good 
for regional 
residuals. The mean 
difference between 
test and retest for 
oral residual was  
-1% and for 
pharyngeal residual 
it was -2%.”  
(p. 39) 
 
Percent retention =  
([radioactive counts 
after the swallow 
averaged over 6 frames] 
/ [initial total area 
counts]) x 
100% 
(Hamlet, 
1996, 
p.43)  
 
 
 
Pharyngeal Retention 
Index (PRI): “the 
residual amount of 
radioactivity in the 
pharynx at 10 and 60 
seconds after 
deglutition” (Galli et al., 
1999) 
Hamlet et al., 
1992 
 
Hamlet et al., 
1994 
 
Hamlet et al., 
1996 
 
Cook et al., 
1994 
 
Shaw et al., 
2004 
Location: 
Oral cavity, 
pharyngeal cavity 
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Flexible Endoscopic Evaluation of Swallowing (FEES) 
Measurement 
Name 
Exam 
Type 
Rating Variable 
Type, Definition, 
and Location 
Timing Reliability Notes 
Relevant 
Publications 
Murray 
Secretions 
Rating Scale 
FEES 
Value (estimation 
by eye): 
Categorical, 
0 – No visible 
secretions anywhere  
1 – Any secretions 
surrounding the 
laryngeal vestibule 
that were bilaterally 
represented or 
deeply pooled 
2 – Any secretions 
that changed from a 
"1" rating to a "3" 
rating during the 
observation period 
3 – Any secretions 
seen in the area 
defined as the 
laryngeal vestibule 
At any time 
during 
demonstration of 
phonatory and 
airway protection 
abilities (scale 
accounts for 
movement of 
secretions over 
time). 
Not reported. 
Rated secretions 
only, not bolus 
residue. 
 
Laryngeal vestibule 
defined as: 
 
(p. 100) 
Murray et al., 
1996  
 
Location: 
Pharynx, larynx 
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Marianjoy  
5-Point 
Secretion 
Severity Scale 
FEES 
Value (estimation 
by eye): 
Categorical, 
1 – Thin, clear 
secretions; <10% 
pooling in the pyriform 
sinuses and/or vallecular 
space  
2 – Mild, pooling of 
pharyngeal secretions 
from 10–25% in 
pyriform sinuses and/or 
vallecular space  
3 – Moderate, pooling of 
pharyngeal secretions 
>25% in pyriform 
sinuses and/or vallecular 
space; no endolaryngeal 
secretions present 
4 – Severe, laryngeal 
penetration of secretions 
above level of true vocal 
cords; intermittent 
laryngeal penetration of 
secretions with 
inhalation; no aspiration 
of secretions; 
endolaryngeal secretions 
present 
5 – Profound, secretions 
present on vocal cords 
and/or tracheal aspiration 
of secretions 
Score is assigned 
at the point of 
maximum 
secretions. 
The inter-rater 
reliability between 
the two raters was 
k=0.850 (p=0.05).  
Rated on 25 still 
images. 
 
Rated secretions 
only, not bolus 
residue. 
 
Modified into 3-
point scale in same 
publication, authors 
recommend either 
scale 
Donzelli et 
al., 2003 
Location: 
Pharynx, larynx 
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Postswallow 
Pooling 
FEES Value (estimation 
by eye): 
Categorical, 
0 
1 
2  
(Undefined 
categories of 
apparent increasing 
severity) 
Unclear. 
Variables were 
scored for each 
FEES swallow at 
varying speed as 
often as 
necessary. 
“Intra- and inter-
rater reliability were 
sufficient for all 
FEES variables 
(weighted kappa > 
0.61).” n=2 
clinicians on 57 
videos 
 
(p. 1056) 
 
 
Residue was defined 
as bolus retention in 
the valleculae or 
pyriform sinuses 
after swallowing  
 
Pilz et al., 
2014 
Location: 
Valleculae, pyriform 
sinuses 
Pharyngeal 
Residue 
Severity Scale 
FEES 
Value (estimation 
by eye): 
Categorical, 
None – No 
pharyngeal coating 
or residue 
Coating – Coating of 
the pharyngeal 
mucosa; no pooling 
Mild – mild 
pooling/residue  
Moderate – 
Moderate 
pooling/residue  
Severe – Severe 
pooling/residue  
Unclear. 
“Raters were 
instructed to 
view the 
recording no 
more than twice 
and to complete 
the scoring in 
one session” (p. 
427) 
Inter-rater reliability 
weighted k=0.51, 
n=15 raters on 30 
videos. 
 
Intra-rater reliability 
weighted k=0.72, 
n=15 raters on 30 
videos. 
At the time of the 
study no published 
pharyngeal residue 
severity scale 
covering FEES and 
videofluoroscopy 
existed and thus the 
authors created their 
own. 
Kelly et al., 
2006 
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Location: 
Pharynx, larynx 
 
Food Residue 
After the 
Swallow 
FEES 
Value (estimation 
by eye): 
Categorical, 
Large amount of 
food residue after 
swallowing 
Small amount of 
food residue after 
swallowing 
Trace amount or no 
residue after 
swallowing 
Unclear. 
Evaluators were 
allowed to repeat 
the viewing of 
FEES videos and 
were allowed to 
use slow motion 
for evaluation. 
Inter-rater reliability 
weighted k=0.3–
0.56, n=9 on 10 
images. 
 
Inter-rater reliability 
weighted k=0.51–
0.75, n=9 on 4 
repeated views. 
None. 
Tohara et al., 
2010 
Location: 
“Epiglottic 
valleculae,” piriform 
sinuses, “pharyngeal 
wall adhesion” 
FEES Residue FEES 
Value (estimation 
by eye): 
Binary, 
None–15% of entire 
bolus 
Retention of >15% 
of a the entire 
material  
After the first 
swallow. 
Not reported. 
Residue was further 
defined as a: “small 
amount of residue 
even after a double 
swallow or medium 
to large amount of 
residue after first 
swallow” even 
though only the 
binary ratings were 
used in analyses.  
Park et al., 
2015 
Location: 
Valleculae, pyriform 
sinuses 
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“A small amount of 
residue (<15%) is 
considered normal.” 
Pooling Score FEES 
Value (estimation 
by eye): 
Categorical, 
Coating  
Minimum (<50% of 
cavity containment 
capacity) 
Maximum (>50% of 
cavity containment 
capacity) 
Correlate 
impressions from 
beginning to end 
of video, but 
“generally the 
most dangerous 
condition must 
be taken into 
account” (p. 138) 
“The site was modified 
by both the first and 
fourth judges over time, 
reaching agreement at 
the last observation [ICC 
(3, k) 0.999]. The 
parameter amount was 
maintained among 
judges [ICC (3, k) 
0.997]. The parameter of 
management was 
replicated by all judges 
in all three observations 
[ICC (3, k) 1.000]. The 
total P-score attributed 
by the four judges con 
firmed that the criterion 
of severity established by 
the first judge was 
essentially shared by the 
other three judges [ICC 
(3, k) 0.999].” (p. 109) 
 
Takes into account 
management of 
residue (“the ability 
of the patient to clear 
the residue”) by 
counting the number 
of clearing swallows, 
along with bedside 
parameters like age 
and sensation. 
Farneti, 
2008 
 
Farneti et al., 
2014 
Location: 
“Vallecula, marginal 
zone, pyriform sinus, 
vestibule/vocal 
cords, lower vocal 
cords” 
BRACS 
(Boston 
Residue and 
Clearing 
Scale) 
FEES 
Value (estimation 
by eye): 
Categorical, 
None/Trace 
<1/3 filled or coated 
1/3–2/3 filled or 
coated 
>2/3 filled or coated 
“The scoring 
instruction sheet 
provides raters 
with detailed 
directions on 
how and when to 
score each 
section when 
 
Inter-rater reliability 
ICC=0.8–0.81, n=4 
on 63 videos. 
 
Inter-rater reliability 
ICCs=0.82–0.92, 
n=4 on same 63 
Unpublished 11-point 
ordinal scale. 
 
An extra point is added if 
residue was noted in 4 or 
more anatomical regions. 
An additional point is 
added if residue was ever 
present inside the 
Kaneoka et 
al., 2013 
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Location: 
12 locations  
(Lateral pharyngeal 
wall/posterior pharyngeal 
wall, base of tongue, 
valleculae/tip of 
epiglottis, left lateral 
channel/left piriform 
recess, right lateral 
channel/right piriform 
recess, post-cricoid 
region, left arytenoid/left 
aryepiglottic fold, right 
arytenoid/right 
aryepiglottic fold, inter-
arytenoid space, 
laryngeal surface of 
epiglottis, laryngeal 
surface of aryepiglottic 
fold and false vocal 
folds, anterior 
commissure/true vocal 
folds, posterior 
commissure) 
reviewing a 
FEES video, 
which helps 
maximize inter-
rater reliability.”  
(p. 313) 
 
Scoring sheet not 
included in 
article. 
views. vestibule  
 
If residue is observed 
and the individual 
demonstrates no 
spontaneous clearing 
swallows, an extra point 
is added to account for 
the apparent lack of 
pharyngeal sensation.  
 
Cued or spontaneous 
swallows are then judged 
for effectiveness 
(yes=80–100% cleared, 
partially=20–80% 
cleared, no=0–20% 
cleared).  
Yale Residue 
Rating 
Severity Scale 
FEES 
Value (matching to 
images by eye): 
Categorical, 
None 
Trace 
Mild  
Moderate  
Severe 
Undefined but 
presumably after 
the swallow(s). 
“Residue ratings 
were excellent for 
intra-rater 
reliability for 
vallecula (kappa = 
0.957 ± 0.014) and 
pyriform sinus 
(kappa = 0.854 ± 
0.021); very good to 
excellent for inter-
rater reliability for 
Definitions were 
anatomically defined, 
image-based, and used a 
five-point ordinal rating 
scale that encompassed 
the full range of severity 
ratings, i.e., none, trace, 
mild, moderate, and 
severe, for both the 
valleculae and pyriform 
sinus locations.  
Only pudding boluses 
were used. 
Neubauer, 
Rademaker, 
& Leder, 
2015 
Location: 
Valleculae, pyriform 
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sinus vallecula (kappa = 
0.868 ± 0.011) and 
pyriform sinus 
(kappa = 0.751 ± 
0.011).”  
(p. 1)  
 
 
  
  
 
(exemplar images for 
moderate residue in 
valleculae and piriform 
sinuses) 
 
 
Table 2. Published scales for rating pharyngeal residue on MBS evaluations, scintigraphy, and FEES. For each scale, the 
definitions of type of rating, residue location, and instructions of when to score residue are described as listed in the original 
publication(s). 
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2.2. Applying Measurement Dimensions to Residue 
 Measurement of residue continues to be limited by a conflict between technology, 
validity, and ease of use. In the absence of ideal methodology for rating residue on FEES, 
the published residue scales outlined in Table 2 have used perceptual measurement, 
meaning one’s subjective estimate about how much residue is present (i.e., moderate, or 
10% filled, etc.). Many of the scales’ authors have also published information on the 
psychometric properties of face validity, concurrent validity, and reliability. Regrettably, 
the existing scales have not evaluated which measurement method best captures the 
construct (Portney & Watkins, 2009). The theoretical underpinnings and psychometric 
properties of the extant residue measures deserve a careful look to determine if they are 
the correct measurement method. Reliability measures are not sufficient for a meaningful 
tool if validity is not also properly evaluated. Consequently, several issues remain with 
the current perceptual scales, such as: 
• Unclear which attributes/features of residue are pertinent (i.e., a gold standard 
quantitative measurement, location of residue, bolus consistency),  
• Uncertainty about pertinent clinician characteristics (i.e., work setting, age), 
• Unclear influence of patient factors (i.e. differences amongst patient populations, 
patient management of the residue, interference with diet and quality of life), and 
• A lack of investigation of measurement dimensions (i.e., measurement 
properties of residue, facets and interrelation of the dimensions, differences 
between rating approaches) (Kempster et al., 2009). 
 
 The last bullet listed above, measurement dimensions, is a particularly interesting 
and unstudied realm for the world of dysphagia and pharyngeal residue. In considering 
measurement dimensions, literature from psychology is helpful, due to the thorough 
investigations done in that field. Dr. Stanley Stevens was a psychologist who dedicated 
his life’s work to developing a theory of levels of measurement. Within his body of work, 
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he described two classes of dimensions: metathetic and prothetic (Stevens, 1975). A 
metathetic dimension varies in changes of quality and is substitutive (for example, the 
pitch of voice is metathetic because as it increases, the quality changes and not the 
quantity). A prothetic dimension is additive because it changes in degrees of quantity or 
magnitude (like the loudness of a sound). Table 2 details the definitions and proposed 
continuum for each type of dimension. Many researchers have adopted Stevens’ methods 
to test the perceptual dimensions of their targeted variable. Examples are the 
intelligibility of speakers with hearing impairment (Schiavetti et al., 1982), stuttering 
(Schiavetti et al., 1983), speech naturalness in amyotrophic lateral sclerosis (Southwood 
1996; Southwood & Weismer, 1993), and voice quality (Toner & Emanuel, 1989; Zraick 
et al., 2000).  
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Dimension 
 
Metathetic Prothetic 
Definition 
Constructs that vary in 
quality/makeup 
when changed 
Constructs that vary in 
quantity/magnitude 
when changed 
Example 
• Pitch of voice 
• Pleasantness of voice 
• Speech naturalness 
• Different colors  
(blue, red, green) 
• Loudness of voice 
• Severity of voice 
• Nasality of voice 
• Stuttering severity 
• Different shades of one color 
(pink, cranberry, magenta) 
Continuum 
Equal spacing with 
clear categories 
(even intervals) 
Can’t subdivide into 
equal intervals, unclear boundaries 
(uneven intervals) 
Level of 
measurement 
Ordinal, interval, or ratio scales 
(i.e. equal-appearing 
intervals/visual analog scale 
or direct magnitude estimation) 
(Cheng, 2006; Yiu & Ng, 2004) 
Ratio scales only  
(i.e. direct magnitude estimation/ 
visual analog scale) 
Notes 
“It is widely agreed that speech 
pathologists use equal-appearing 
intervals scales because they are 
accessible, easy to use and 
interpret, and easy to compare 
across patients and listeners”  
(Baylis et al., 2015, p. 661) 
Self-administered, visually-
dependent (not verbal),  
reports of equivocal or higher 
sensitivity and reliability to equal-
appearing intervals 
(Funke & Reips, 2012; Averbuch 
& Katzper, 2004; Ahern, 1997; 
Gerratt, 1991; 1993) 
Table 3. Examples of metathetic versus prothetic dimensions of measurement. 
 Before a measurement scale is created, the dimensions of the targeted variable 
must be studied to know the best way to measure it. It is curious that no other literature in 
the field of deglutition has documented any comments about the measurement 
dimensions of residue. The field of voice has investigated measurement dimensions due 
to a struggle with rating ‘how much’ of a perceptual quality exists in a voice disorder 
(breathy, rough, strained, etc.). Beginning in 1989, researchers in the field of voice began 
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investigating the use of a VAS or direct magnitude estimation (DME), which uses a 
modulus for basis of comparison for ratings along a continuum (Toner & Emanuel, 1989; 
Kreiman et al., 1992; Gerratt et al., 1991; 1993; Zraick et al., 2000B). A modulus is an 
example to provide a basis for comparison, be it a neutral example or one of the 
extremes. Authors found that ratio scales such as DME and VAS were more reliable and 
more valid than the ordinal or interval scales such as 5-point, 7-point, or 9-point Likert or 
categorical scales (Eadie & Doyle, 2002; Cheng, 2006; Yiu & Ng, 2004). In 2002, Eadie 
and Doyle used Stevens’ methods and found that overall voice severity is best rated with 
a ratio scale allowing for unequal intervals such as a VAS. The authors wrote, “it is vital 
that more global auditory-perceptual judgments of voice are validly scaled” (Eadie & 
Doyle, 2002, p. 3020). The research led to the Consensus Auditory-Perceptual Evaluation 
of Voice (CAPE-V), a widely used measurement tool for voice disorders based on a VAS 
(Zraick et al., 2011; Helou et al., 2010; Kempster et al., 2009). It serves as a reference 
standard in the absence of a gold standard and the excellent investigatory work to verify 
its psychometric properties makes it a stronger tool. 
 Residue should be assessed, as voice quality was, to determine if it is metathetic 
or prothetic in nature. This will assist in scale development to determine the proper 
continuum to use when measuring residue. Such an investigation will help to support the 
use of a scale with either equal-appearing intervals or an unrestricted continuum. It is 
hypothesized that the psychophysical attributes of residue are prothetic because they vary 
in quantity and magnitude.  
 There has never been a greater need than now for a measurement tool to rate 
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residue on FEES. It is possible that part of the problem in measuring residue has been 
that the extant scales do not adequately capture the psychophysical nature of residue and 
an unrestricted continuum such as a visual analog scale would be more appropriate. It is 
vital to have a global estimate that is valid to allow for meaningful measurement of the 
amount of residue. If the field of voice can develop measures for what was once thought 
to be an ‘unmeasureable’ variable, then there is no reason why residue cannot be 
measured. This work has taken on the challenge to examine the construct of residue and 
the best way to measure it.
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CHAPTER THREE 
Dissertation Purpose and Methods 
ABSTRACT 
The purpose of the first part of this chapter is to describe the rationale for re-thinking 
scale development for rating residue on FEES. The second part of the chapter describes 
the methods of the dissertation work, specifically how the investigation was carried out 
for clinicians to systematically rate 81 FEES videos across two sessions. The following 
methods are described: how clinicians were selected, how videos were collected and 
edited, and how the procedure was carried out to collect clinician ratings of videos. 
Lastly, the dissertation’s three research questions are posed, along with the statistical 
methods that were applied to each of the research questions.  
 
3.1 The Rationale for Rethinking Scale Development 
 Despite ample research that suggests pharyngeal residue is a concerning outcome 
of swallowing disorders, it remains unclear how the amount of residue relates to the 
severity of disease and other outcomes. The unknown variable of ‘amount’ is 
undoubtedly related to a measurement problem. Several perceptual scales exist that 
attempt to estimate residue amount as seen on FEES, but the scales have had little impact 
on the field likely because they lack clinical validity and generalizability (Neubauer et al., 
2015, Kaneoka et al., 2013, Farneti et al., 2006). Further, the evidence provided for other 
scales consists only of concurrent validity and reliability without any sensitivity or 
specificity testing due to the lack of a gold standard (Martin-Harris et al., 2009; Zraick et 
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al., 2011). Having a more accurate measure of residue may translate into a more useful 
tool, but this will remain unknown until a gold standard is developed for FEES. In the 
meantime, the psychometric properties of residue measures can be evaluated. 
 As put forth in Chapter 2, the psychometric properties of residue measures of 
pharyngeal residue are unstudied. This step is arguably the most important for scale 
development. An important question to answer is: do the dimensions of residue exist on 
an even or uneven spectrum? The field of voice has established that certain properties of 
voice quality should be measured with magnitude estimation, not with ranked categorical 
scales like mild, moderate, and severe (Brancamp et al., 2010; Eadie et al., 2006; Baylis 
et al., 2015). Figure 8 demonstrates the concept of equal versus unequal intervals. 
 
Figure 8. A schema to demonstrate the concept of equal intervals versus unequal intervals 
that can be applied to any field of measurement. 
 The most universally accepted rating scale for pharyngeal residue is a categorical 
rating (i.e., mild, moderate, severe). Because of its widespread use and familiarity, this 
type of a rating scale may be the preferred method of perceptual measurement. The 
categories are usually ordinal and assumed to be evenly spaced. However, their use 
should be challenged given the lack of impact thus far in establishing the relevance of 
residue with categorical ratings. For one, the degree of precision is limited when choices 
are in categories. A rater might want to suggest that the amount of residue is on the more 
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severe side of a ‘mild-moderate’ rating. Two, it is not clear from a categorical perspective 
if the distance between mild to moderate is the same as moderate to severe. Finally, the 
statistical tests used for ordinal scales are limited in statistical power. 
 A continuous scale might provide greater accuracy and efficiency. A visual 
analog scale (VAS) is a quantitative estimate of the magnitude of the desired entity, in 
this case: residue. A visual analog scale is typically a 100-millimeter line with a label, or 
‘anchor,’ on either end. The rater simply marks their response with a slash on the line at 
the perceived magnitude of the variable being measured. The rating, then, is a measure of 
length (in mm) from the left end of the line to the slash, resulting in a ratio or continuous 
variable. The VAS has become an established measurement tool to measure change over 
time in pain, mood, and voice. Maybe, then, residue is best measured with a VAS. 
Perhaps the stark method of boxing a perceptual impression into categories precludes 
precision in the clinician’s judgment.  
 It is a given that no clinical measurement tool can resolve all of the relevant issues 
such as validity, reliability, and utility. Nonetheless, the goal of this body of work is to 
better understand perceptual judgments of residue and the influence of a VAS versus a 
categorical scale on clinician ratings. More specifically, this dissertation investigates 3 
questions: 
 Q1) Which rating method  (VAS or categorical) has better inter-rater and  
         intra-rater agreement? 
 Q2) Do VAS ratings of residue severity correlate with categorical ratings? How  
         do these findings clarify characteristics of the measure of residue? 
 Q3) Do ratings of residue severity cluster in certain areas of significance? How  
                    does this inform scale development and what is the clinical significance of     
         the clusters? 
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3.2 Dissertation Methods 
 This study used a prospective design to investigate clinician ratings of residue on 
FEES videos at two different time points. Speech-language pathologists were asked to 
rate FEES videos twice, each time with a different rating method. The Institutional 
Review Board for Boston University Medical Center reviewed this protocol and deemed 
it exempt (H-33946). 
 A) Clinicians: A total of 33 clinicians participated. The goal was to obtain a wide 
range of clinicians to represent the larger population of speech-language pathologists. 
Therefore a convenience sample strived to obtain roughly equal numbers of students (<1 
year of experience in interpreting FEES and/or MBS studies, n=10), proficient clinicians 
(2 to <6 years experience, n=8), and advanced clinicians (6–10 years experience, n=11). 
There were 4 clinicians designated as experts, defined as >15 years experience with 
FEES (ranging from 15–31 years). The number of experts needed was calculated based 
on sample size calculations for the number of experts needed for judgment studies 
(sampling estimates of a mean reliability of >0.8; Rosenthal, 2005; 1966). The number of 
years of experience was self-reported as part of the clinician demographic data along with 
self-report of their work setting (nursing home, inpatient care, etc.).  
 A total of 33 clinicians participated: 31 females and 2 males, which is 
representative of the general body of speech-language pathologists. The average years of 
experience performing and interpreting FEES was 6.2 (ranging from 0–31) and the 
average years of experience performing and interpreting MBS exams was 9.8 (ranging 
from 0–10). In the following environments, clinicians reported performing FEES and/or 
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MBSes: outpatient (n=14), inpatient (n=24), nursing home/skilled nursing facilities 
(n=2), acute or long term acute rehab (n=10), not applicable (n=4), and other: via 
teaching or research capacity only (n=2). 
 B) Videos: The FEES videos were prospectively collected from patients seen for a 
swallow evaluation in the outpatient clinic of an urban hospital. The patients in the videos 
were mostly head/neck cancer patients who had undergone both surgical and 
radiation/chemoradiation treatment (23.1%). Other etiologies were surgeries such as 
thyroidectomy and anterior cervical discectomy/fusion (10.3%), head/neck cancer treated 
with only radiation/chemoradiation (7.7%), head/neck cancer treated with only surgery 
(7.7%), stroke (7.7%), Parkinson’s disease (5.1%), voice or breathing disorders (5.1%), 
other cancer (2.6%), GERD (2.6%), multiple etiologies (17.5%), and other (15.4%). 
Videos were selected to be used for the study if there was a clear view of the 
larynx/pharynx and if any of the following boluses were administered with two drops of 
green food dye: 5mL thin liquid via spoon, 5mL applesauce via spoon, ¼–½ Saltine 
cracker. Videos were excluded if no swallow was elicited, there was pre-existing residue, 
no green food dye was used in the bolus, or there was no audio recording to identify the 
volume or type of bolus administered. 
 Each video was edited to remove audio and any patient identifiers. The edited 
videos ranged from 14 to 46 seconds in total length. All videos were presented in the 
same exact format: a 3-second title listing the bolus amount and consistency (“5mL 
applesauce”) followed by video of before, during, and after the swallow. The videos 
contained instruction titles to “1. Score Now” for the period of time after the first swallow 
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and “2. Score Now (clearing swallow)” for the period of time after the very last clearing 
swallow(s). Figure 9 demonstrates 3 examples. In the case that there were not any 
clearing swallows, an instruction title appeared that said: “2. Clearing Swallow N/A.” 
Each video was numbered to correspond with rating sheets in the provided packet (see 
Procedure).  
   (A.)                                         (B.)                                       (C.) 
                    
                  
Figure 9. Images taken from FEES videos as examples of residue after the first swallow and 
after the clearing swallows for (A) thin liquid residue, (B) applesauce residue, and (C) 
cracker residue. 
 The videos were categorized by consistency and residue severities until enough 
were collected to complete the following categories: 25 videos of 5mL thin liquid (5 no 
residue, 5 trace/coating, 5 mild, 5 moderate, and 5 severe), 25 videos of 5mL applesauce 
(5 no residue, 5 trace/coating, 5 mild, 5 moderate, and 5 severe), and 25 videos of ¼–½ of 
a Saltine cracker (5 no residue, 5 trace/coating, 5 mild, 5 moderate, and 5 severe).  
 To categorize the videos according to residue severity, two experienced raters 
independently rated the overall residue severity using a previously published perceptual 
scale of none, trace/coating, mild, moderate, severe (Kelly et al., 2006). This scale was 
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used due to a lack of any other appropriate scale or gold standard for determining the 
overall amount of residue of various bolus consistencies on FEES. Disagreements in 
ratings between the 2 raters were resolved via discussion so that there was 100% 
agreement in categorization of the videos and what resulted was an adequate variety of 
residue presentations.  
 In order to determine intra-rater reliability within a session, the 3 best quality 
applesauce and cracker videos were selected to be repeated within the same session: 1 
mild, 1 moderate, and 1 severe residue severity. Thin liquid videos were not used for 
intra-rater reliability due to the known variability in ratings (Park et al., 2014). Thus, in 
addition to the 75 videos, 6 were repeated within the same session making for a total of 
81 videos presented in each session. 
 Furthermore, for each video, diet and quality of life information was collected 
from the patient in that video. Diet was measured using the Functional Oral Intake Scale 
(FOIS; Crary et al., 2005) that was completed by the clinician, and the patient’s quality of 
life was measured using the Dysphagia Handicap Index (DHI), completed at the time of 
the visit by the patient (Silbergleit et al., 2012). Two trained raters also independently 
rated each video using the Penetration-Aspiration Scale score (PAS; Rosenbek et al., 
1996) and the timing of the PAS event (before/during/after the swallow). Table 3 lists the 
variables that were collected for each video, the measurement tool, and the type of 
variable. 
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Variable Measure Variable Type 
Penetration and aspiration Penetration-Aspiration Scale 
Score (Rosenbek et al., 1996) 
Ordinal, 1–8  
(normal–severe) 
Quality of life Dysphagia Handicap Index 
(DHI; Silbergleit et al., 2012) 
Ordinal, 1–7 
(normal–severe) 
Diet Functional Oral Intake Scale 
(FOIS; Crary et al., 2005) 
Ordinal, 1–7 
(normal–severe)* 
Clinicians’ VAS rating for 
how much overall residue 
was seen 
Visual-analog scale  
(None–Severe) 
Continuous,  
1–100mm 
Clinicians’ categorical rating 
for how much overall residue 
was seen 
None, Trace/Coating, Mild, 
Moderate, Severe (Kelly et al., 
2006) 
Ordinal, 1–5  
Clinicians’ VAS rating for the 
effectiveness of the clearing 
swallow 
Visual-analog scale  
(None–Severe) 
Continuous,  
1–100mm 
Clinicians’ categorical rating 
for the effectiveness of the 
clearing swallow  
None, Trace/Coating, Mild, 
Moderate, Severe (Kelly et al., 
2006) 
Ordinal, 1–5  
(normal–severe) 
Amount of residue in each of 
3 zones 
Swallowtail FEES® computer 
program 
Continuous,  
1 – 100 % 
Overall amount of residue Swallowtail FEES® computer 
program 
Continuous,  
1 – 100 % 
Table 4. Variables collected for each FEES video for the dissertation. *The FOIS originally 
is written as 7 (normal) to 1 (severe), but this was reversed so that the direction of all 
ordinal variables would be consistent. 
 
 C) Procedure: The clinicians were recruited via word of mouth. Participation 
occurred in small groups of <5 clinicians. Each clinician was given a packet for scoring 
and a pencil. As the clinicians viewed each FEES video, they answered two simple 
questions: (1) “Overall, how much residue do you see?” and (2) “How effective were the 
clearing swallows (if present)?” The packet for responses contained 81 sheets of paper, 
one for each of the 81 videos. The rating method for each sheet of paper was randomized 
to either categorical or VAS. On the categorical rating, choices were: none, trace/coating, 
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mild, moderate, or severe for the first question about overall amount of residue and very, 
somewhat, or not effective for the second question about effectiveness of clearing 
swallow. On the VAS ratings, participants were asked to mark a slash (/) on the 100-mm 
line according to the impressions of residue severity. The line had small text grey text as 
anchors, “None” on the left and “Severe” on the right. No tick marks were placed 
anywhere on the line. No operational definitions were provided for severity because this 
study aimed to compare the unprompted internalized scales of each clinician without any 
priming. Figure 10 shows a schema of the presentation of rating method. 
 
SESSION I: 81 videos 
 
 
 
 
 
SESSION II ~ two weeks later: same 81 videos with opposite rating method  
 
Figure 10. A representation of the randomized but counter-balanced presentation of rating 
methods. 
 
 In the first session, clinicians viewed the 81 edited FEES videos and rated their 
impression of residue severity for each video. In the second session, they rated the same 
81 videos. The type of rating method for residue severity for each video was the opposite 
of the first session. The rating method was planned such that every video would receive 
both a categorical and a VAS rating after both sessions were completed. The categorical 
….. 
Video 81 
….. 
Video 1 Video 2 Video 3 
CATEGORICAL VAS VAS 
Video 2 
CATEGORICAL 
Video 81 
VAS 
Video 1 
VAS 
Video 3 
CATEGORICAL 
CATEGORICAL 
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and VAS rating methods were presented in the first session in a randomized order to 
avoid any repetitive answering effects. In the second session, the order was 
counterbalanced to change the rating method for each video. Clinicians were not told how 
many of each severity they would see. Clinicians participated in 2 viewing sessions, 
ideally separated by at least two weeks, but in certain situations due to scheduling 
challenges, the sessions were closer together. The mean number of days between sessions 
was 11.9 and the median was 14 (range: 1–34 days). During the sessions, the videos were 
displayed in a dark room on a bright 13-inch high retina full-screen computer display that 
was placed within 5 feet of the clinicians. They were allowed to watch the videos as 
many times as requested, as well as pausing at requested time points or using slow 
motion. Sessions ranged from 45 minutes to 1.5 hours. Each clinician was given $60 
upon completion of both sessions to compensate for their time and knowledge. 
 D) Statistical Methods: Table 3 lists the variables included in the study and how 
they were treated in statistical analyses. The sample size of the number of required 
clinicians was determined by the desired analyses. For correlations of VAS, at least 13 
clinicians were needed to provide adequate power for Spearman rank’s coefficient 
(alpha=0.05, beta=0.2, r=0.7). For correlations of categorical ratings, at least 25 clinicians 
were needed to provide ratings (five ratings in each of the 5 categories across severity 
levels) because the anticipated statistical calculations require at least 5 in each cell for 
adequate power. It was impossible to ensure an even spread of ratings due to inability to 
predict how a clinician would rate a video, so additional clinicians were enrolled to 
ensure an adequate number in the targeted severity level. Statistical tests were performed 
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on Microsoft Excel (version 14.4.0), SAS (version 9.4), and IBM SPSS Statistical 
software (version 24), depending on the desired analyses. The statistical methods for each 
of the research questions are outlined below. A p-value of <0.05 was regarded as 
significant throughout all analyses. 
 
Q1) Which rating method (VAS or categorical) has better inter-rater and intra-
rater agreement?  
 To determine if one method yielded greater consensus amongst raters, intra-class 
correlation coefficients (ICC) were determined for categorical ratings and VAS ratings. 
This test is a strong statistical analysis to simultaneously assess correlation and agreement 
among multiple raters. Many studies have shown ICC analyses can be used for 
continuous or ordinal data when intervals are assumed to be equivalent (Portney & 
Watkins, 2009; Tinsley & Weiss, 1975). The raw data for each clinician (n=33) were 
entered into an SPSS computer program and reliability analyses were as follows for both 
categorical and VAS ratings: a two-way random model (2,1) was used, estimates were 
based on absolute agreement, not consistency, and a 95% confidence interval was 
calculated. To compare reliability of experts independently (n=4) and all other clinicians 
(n=29), two-way mixed models were used (3,1) due to the fixed set of raters. It was 
hypothesized that categorical ratings would demonstrate an ICC<0.7 (Tohara et al., 2010; 
Kaneoka et al., 2013) and VAS ratings would demonstrate an ICC >0.7, given the 
evidence from preliminary data (Pisegna & Langmore, 2015).  
 To determine intra-rater reliability, weighted kappas were used for categorical 
  
58
ratings and Lin’s concordance coefficient was used for VAS ratings (Lin, 1989; 2000). 
ICCs were not employed for intra-rater reliability measures due to a concern for 
homogeneity in ratings that would negatively interfere with the much-needed source of 
variance for ICC measures (Portney & Watkins, 2009). Rather, a weighted kappa is a 
numeric index ranging from 0–1 that assesses agreement along an ordinal scale that gets 
progressively more severe (weighted more severely). It also accounts for agreement by 
chance. Lin’s correlation is a numeric index ranging from 0–1 and assesses the degree of 
agreement between two continuous measures along the 45-degree slope line to account 
for concordance and discordance. Chance-agreement is also factored into the statistic, 
making it a stronger analysis than other correlation analyses.  
 The ratings from the 6 repeated videos within each session were used for the 
intra-rater data analyses, 3 applesauce videos and 3 cracker videos. Thin liquid videos 
were not used for intra-rater data due to the variability in ratings (Park et al., 2014) and 
prioritization to reduce participant burden related to attention span and length of session. 
Not all of the clinicians rated the repeated videos due to an administrative error in the 
distributed packets. Pre-defined interpretation levels were assigned to the weighted kappa 
levels: <0.2=poor, 0.21–0.4=fair, 0.41–0.6=moderate, 0.61–0.8=good, and 0.81–
1.0=excellent (Altman, 1991). Pre-defined interpretation levels were assigned to the Lin’s 
concordance coefficients, adjusted by 0.1 given a lack of established interpretations for 
the field of dysphagia and given that the published classifications are based on non-
human research: <0.6=poor, 0.61–0.8=good, 0.81–1.0=excellent (McBride, 2005). It was 
hypothesized that intra-rater agreement would be stronger for categorical ratings than 
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VAS ratings, based on anecdotal experience. SAS was used to calculate the kappa 
statistics of the categorical variables; in cases where the data entry table was non-square, 
dummy weights were added to prevent errors in the calculations. An online site was used 
for Lin’s calculations (“Statistical Calculations: Lin’s Concordance,” 
https://www.niwa.co.nz/node/104318/concordance was used for analyses). 
 To investigate differences in clinicians versus expert clinicians, only VAS ratings 
were analysed due to stronger statistical analyses over the categorical data. The VAS 
ratings were categorized by clinician type into 3 groups: novice clinicians (0–1 years of 
experience with FEES), proficient clinicians (2–9 years of experience with FEES), and 
experts (15+ years experience with FEES). Outliers, defined as ± 3 standard deviations, 
were removed to meet the assumptions of the desired ANOVA testing. From the cracker 
videos, there were n=0, 5, 3, 0, and 0 outliers in the none, trace, mild, moderate, and 
severe categories, respectively. From the applesauce videos, there were n=4, 3, 4, 0, and 
3 outliers in the none, trace, mild, moderate, and severe categories, respectively. From the 
thin liquid videos, there were n=4, 5, 1, 5, and 0 outliers in the none, trace, mild, 
moderate, and severe categories, respectively. SAS was used to calculate a two-way 
ANOVA to determine if there was an interaction of (1) clinician grouping by years of 
experience and (2) severity VAS ratings of residue on cracker and applesauce. 
 
Q2) Do VAS ratings of residue severity correlate with categorical ratings? How do 
these findings clarify characteristics of the measure of residue? 
 Spearman rank correlations were used to examine the strength of association 
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between the continuous and ordinal variables. Based on previous data (Pisegna & 
Langmore, 2015), it was hypothesized that the VAS and categorical ratings would 
correlate with a value >0.70. For interpretation purposes, an r value of >0.75 was 
regarded as a strong correlation. Scatter plots and exploratory statistics were used to 
begin inspection of the data and trends (Rousson, Gasser, & Seifert, 2002). Upon 
inspection of the correlations it was determined that there was a non-linear trend to the 
plots, so assessments of linear versus quadratic fit were performed using generalized 
linear modeling. In these assessments, the arithmetic means for categorical ratings were 
calculated for each video; the geometric means for VAS ratings were calculated for each 
video. This was a necessary step to allow comparison of the psychometric properties of 
each scale (Stevens, 1975). The r2 value and term coefficients of linear versus quadratic 
models for cracker, applesauce, and thin liquid videos were compared to each other using 
methods described elsewhere (McDonald, 2014). In accordance with previous work, a 
non-linear fit of the model would indicate an unequal interval dimension of residue 
(prothetic) while a linear fit would describe equal intervals of the properties of residue 
(metathetic; Stevens, 1975; Baylis et al., 2015; Eadie & Doyle 2002; Brancamp et al., 
2010). SAS (version 9.4) was used for these analyses. 
 
 Q3) Do ratings of residue severity cluster in certain areas of significance? How does 
this inform scale development and what is the clinical significance of the clusters?  
 Given the results from question 2 above, an investigation of ‘clustering’ of ratings 
was performed to confirm or identify any further trends in the data. It was hypothesized 
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that the VAS ratings would have large standard deviations and a lack of trend. It was also 
hypothesized that the categorical ratings would demonstrate wide clusters given previous 
variability reports (Kelly et al., 2006; Pisegna & Langmore, 2015; 2016). To determine 
clusters of ratings for each severity type, all outliers were removed from the dataset. 
Outliers were defined as residue ratings ±3 standard deviations (SD) or ±1 interquartile 
range (IQR).  
 On the VAS, means and SD were calculated and the upper boundary of each 
severity level’s SD was used as a threshold to define the boundary of clusters. 
Categorical averages were determined by median and the IQR was used as a threshold to 
define the boundary of clusters. Microsoft Excel was used for the graphic work. To 
compare the clusters, both the continuous and ordinal data were compared using the 
Kruskall-Wallis test of differences between mean ranks. Follow-up tests were conducted 
to evaluate pairwise differences among the groups, controlling for Type I error across 
tests by using a Bonferroni correction in a ninja fashion. SPSS version 24 was used for 
analyses.  
 To assess for clinical significance of the clusters, further testing was done to 
analyze the differences between quality of life, diet, and PAS ratings depending on the 
ratings. Medians and means of the FOIS and DHI were calculated to determine data 
normality and distribution in addition to skewness that could influence testing. It was 
necessary to reverse code the values for the FOIS because the positive and negative ends 
of that scale (1 bad – 7 good) were opposite to that of the DHI and PAS (1 good – 7 bad). 
Regarding the clinical data, 37/75 videos contained FOIS data, 23/75 videos contained 
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DHI data, and 74/75 videos contained PAS data. The missingness is due to a lack of data 
collection in the archived videos or an inability to discern the information from the video 
or chart review. In one example, PAS would be missing if the entire vestibule was not 
visualized during the video thus precluding a PAS assignment. In another example, diet 
information may not have been assessed fully during the clinical interview thus 
precluding a diet score. Spearman’s correlations were used for comparison of VAS to 
ordinal variables. Mood’s median test was employed as a cruder Kruskall-Wallis test for 
the ordinal data due to the smaller sample size and non-parametric status of the scores. 
Post-hoc testing consisted of pairwise comparisons of medians including adjustments for 
multiple tests via Bonferroni correction. If two categorical variables were isolated for 
comparison in risk of aspiration, risk ratios were calculated in 2x2 tables. If there were 
cells with a value of 0, then 0.5 was added to all cells (Pagano & Gauvreau, 2000; Deeks 
& Higgins, 2010). SPSS version 24 was used for these analyses. 
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CHAPTER FOUR 
Dissertation Results  
Abstract 
This chapter describes the results for the three research questions of the dissertation work. 
In brief, (1) Clinicians demonstrated slightly better reliability with VAS ratings than with 
categorical ratings, although all were at acceptable levels, and there was no significant 
difference between clinician and expert ratings; (2) VAS and categorical ratings were 
highly correlated and fit a curvilinear model with significantly less variance than a linear 
model, suggesting that the psychometric properties of the current rating methods exist on 
a spectrum in unequal intervals; and (3) Groupings, or ‘clusters,’ of ratings along the 
unequal spectrum were associated with penetration and aspiration but not diet or quality 
of life measures.  
 
4.1 Dissertation Results 
4.1a. Reliability of Residue Ratings and Expert Ratings 
 
Q1) Which rating method has better inter-rater and intra-rater agreement? 
 Both rating methods demonstrated acceptable inter-rater reliability. The intra-
class correlation (ICC) correlation coefficients for the inter-rater reliability are listed in 
Table 5. For both VAS and categorical ratings, there was an acceptable reliability of 
>0.80 between all raters for all boluses. There were smaller ICCs for thin liquid ratings 
on both VAS and categorical ratings (0.7–0.8), but they were still above the pre-selected 
cut point of acceptability (ICC>0.7). Clinician ICCs were nearly identical to expert ICCs 
on most comparisons.  
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Inter-Rater Reliability for VAS Ratings 
All Raters 
ICC (n=33) 
Clinicians Only 
ICC (n=29) 
Experts Only 
ICC (n=4) 
All cracker boluses (n=25) 0.83 0.82 0.86 
All applesauce boluses (n=25) 0.87 0.87 0.87 
All thin liquid boluses (n=25) 0.73 0.73 0.70 
All boluses (n=75) 0.82 0.81 0.82 
 
Table 5. Inter-rater reliability coefficients (intra-class correlations; ICC) for visual analog 
scale (VAS) and categorical ratings across bolus types and clinician types. 
 
 For intra-rater reliability, clinicians rated the same cracker and applesauce 
videos twice with each rating method. The reliability coefficients for the VAS ratings 
were higher than the coefficients for categorical ratings. For all VAS repeated ratings 
(applesauce and cracker combined), the agreement was 0.90 and interpreted as 
‘excellent.’ For all categorical repeated ratings (applesauce and cracker combined), the 
agreement was 0.78 and interpreted as ‘good.’ The cracker and applesauce reliability 
indices are listed in Table 6, along with the lower and upper 95% confidence limits. Of 
note, these reliability coefficients and confidence limits cannot be numerically compared 
because of the use of disparate statistical testing procedures. In general, intra-rater 
reliability for just the applesauce ratings was excellent. For cracker ratings, the VAS 
ratings showed excellent agreement while the categorical ratings were only ‘good.’ 
 
Inter-Rater Reliability for Categorical Ratings 
All Raters 
ICC (n=33) 
Clinicians Only 
ICC  (n=29) 
Experts Only 
ICC (n=4) 
All cracker boluses (n=25) 0.87 0.86 0.89 
All applesauce boluses (n=24) 0.90 0.94 0.94 
All thin liquid boluses (n=24) 0.78 0.78 0.82 
All boluses  (n=73) 0.86 0.85 0.89 
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 Intra-Rater Reliability  
 
Coefficient 
Lower 
95% CL 
Upper 
95% CL 
All cracker boluses 
(n=56) 
VAS Ratings 
rc=0.86 
EXCELLENT 
0.79 0.91 
Categorical Ratings 
k=0.73 
GOOD 
0.61 0.84 
All applesauce 
boluses (n=73) 
VAS Ratings 
rc=0.92  
EXCELLENT 
0.87  0.95  
Categorical Ratings 
k=0.83 
EXCELLENT 
0.75 0.91 
All boluses (cracker 
and applesauce) 
(n=129) 
VAS Ratings 
rc=0.90  
EXCELLENT 
0.86 0.93 
Categorical Ratings 
k=0.78 
GOOD 
0.71 0.85 
Table 6. Intra-rater reliability coefficients for VAS (Lin’s correlation coefficient, rc) and 
categorical ratings (weighted kappa, k). The lower and upper 95% confidence limits (CL) 
are provided. 
 It was intriguing that expert ratings were in high agreement with the other 
clinicians. Therefore, further analyses were performed to investigate expert differences, 
as they are often used as a reference standard in the absence of a gold standard 
(Hutcheson et al., 2016; Neubauer et al., 2015; Kaneoka et al., 2013; Martin-Harris et al., 
2008). Cracker and applesauce residue ratings on the VAS were analyzed using a two-
factor ANOVA to assess for any differences in residue ratings between 3 groups of 
clinicians. The groups were defined as 0–1 years (novice), 2–9 years (proficient), and 15+ 
years (expert) of experience with FEES. Factor 1 was the clinician group and factor 2 was 
residue severity. Analyses only involved the VAS ratings, which allowed for statistical 
tests with greater power.  
 Figure 11 demonstrates the comparisons within the cracker and applesauce 
videos. For the cracker videos, there was an overall significant interaction in the model 
(df=14, F=145.72, p<0.001). There was no significant source of variance between the 
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clinician groups (df=2, F=0.88, p=0.4140), but there was an expected significant source 
of variance in the severity levels of cracker residue amount (df=4, F=508.91, p<0.0001). 
Tukey’s test was used for post-hoc testing and all cracker severity levels were 
significantly different from one another (p<0.05). For applesauce videos, there was no 
significant difference in the ratings between novice, proficient, and expert raters (df=2, 
F=2.19, p=0.1130). There was, again, an expected significant source of variance in the 
severity levels of applesauce residue amount (df=4, F=1328.9, p<0.0001). Tukey’s test 
was used for post-hoc testing and all severity levels were significantly different from one 
another (p<0.05). Thin liquid videos were not analyzed due to lower inter-rater reliability. 
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Figure 11. Average visual analog scale ratings for all bolus severity types by novice, 
proficient, and expert clinicians. Applesauce and cracker bolus types are demonstrated 
(thin liquid ratings were excluded due to lower reliability in the ratings). Error bars are +1 
standard deviation. 
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4.1b. Comparing Visual Analog Scale Ratings to Categorical Ratings  
 
Q2) Do VAS ratings of residue severity correlate with categorical ratings? How do 
these findings clarify characteristics of the measure of residue? 
 Direct comparisons of VAS to categorical ratings were plotted against one another 
to look for patterns. VAS ratings were highly correlated with categorical ratings for each 
type of residue severity. Spearman rank correlation coefficients for thin liquid videos, 
applesauce videos, and cracker videos were r=0.85 (n=824), r=0.92 (n=824), and r=0.90 
(n=825), respectively, all of which were significantly different from r=0 (p<0.0001). 
However, the plots of the data points demonstrated a non-linear curve so further testing 
was undertaken, in accordance with the statistical methods described in Chapter 3. In 
comparing the linear fit of the data to a quadratic fit, all the r2 values significantly 
improved for the thin liquid, applesauce, and cracker models, as outlined in Table 7. 
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Bolus Type 
(n) 
Equation  
(p-value) 
r2 Figure 
Linear 
Modeling 
Thin Liquid 
(n=25) 
y= -22.64 + 17.48x   
p<0.0001 
0.85 
 
Applesauce 
(n=25) 
y= -32.51 + 22.97x   
p<0.0001 
0.93 
 
Cracker 
(n=25) 
y= -32.35 + 21.11x   
p<0.0001 
0.91 
 
Quadratic 
Modeling† 
Thin Liquid 
(n=25) 
y= 14.32 -17.80x + 6.73x2  
p<0.0001 
0.98* 
 
Applesauce 
(n=25) 
y= 8.32 -12.33x + 5.88x2  
p<0.0001 
0.99* 
 
Cracker 
(n=25) 
y= 10.20 -13.94x + 6.03x2   
p<0.0001 
0.98* 
 
Table 7. Linear versus quadratic modeling of categorical and visual analog scale rating of 
residue. *Significantly different than respective r2 values of the same bolus type’s linear 
model r2 value (p<0.0001). †The equations listed here were done on transformed data in 
accordance with the described psychometric testing. The descriptive text lists other 
quadratic equations that can be used without transforming data. 
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 The significant findings show that clinician ratings of the data are best fit with a 
curvilinear model, which suggests that the dimension of the residue ratings is perceived 
to have unequal intervals (Stevens, 1975). Using these novel models, values on each scale 
can be predicted using the quadratic regression line while accounting for the unequal 
spacing. That is, categorical ratings (x) can be calculated to predict VAS ratings (y) and 
vice versa. It is recommended that the following equations be used for conversions, 
which do not rely on any transformation of the data and will still account for predictions 
of unequal spacing: cracker y=(-0.7)+(-1.56x)+(3.67x2), applesauce y=(-1.46)+(-
0.07x)+(3.56x2), thin liquid y=(5.08)+(-6.05x)+(4.18x2). 
 
4.1c. Determining Meaningful Clusters of Ratings 
 
Q3) Do ratings of residue severity cluster in certain areas of significance? How does 
this inform scale development and what is the clinical significance of the clusters? 
 
 The VAS and categorical data demonstrated several patterns outlined below that 
confirm the previous result of non-linear spacing of the variables. Given the novelty of 
this finding, further investigation of the trends was pursued to investigate the meaning 
behind the groupings, or clusters, of data for each rating method. The clusters were 
influenced by several different factors such as severity of residue, bolus type, and clinical 
significance, described below. 
 Severity of Residue 
 Clinicians provided five statistically different severity levels of residue for cracker 
and applesauce videos, but not thin liquid videos. Average VAS and categorical ratings 
for each severity level were as follows in Table 8: 
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 None Trace Mild Moderate Severe 
 
Cracker 
Average 
VAS  
Rating  
(SD) 
2.79mm  
(0, 6.2mm) 
13.29mm  
(3.0, 23.6mm) 
21.98mm  
(5.7, 38.3mm) 
54.55mm  
(31.8, 77.3mm) 
70.40mm  
(50.3, 90.5mm) 
Applesauce 
1.69mm  
(0, 3.5mm) 
11.21mm  
(3.2, 19.3mm) 
24.07mm  
(10.1, 38.1mm) 
73.19mm  
(53.1, 93.3mm) 
84.69mm  
(71.2, 98.2mm) 
Thin Liquid 
3.22mm  
(0, 6.79mm) 
3.39mm  
(0, 7.7mm) 
19.32mm  
(6.4, 32.2mm) 
17.59mm  
(4.3, 30.9mm) 
53.81mm  
(25.4, 82.2mm) 
 
 None Trace Mild Moderate Severe 
 
Cracker 
Median 
Categorical  
Rating 
(IQR) 
none  
(0) 
trace  
(none–mild) 
mild  
(trace–moderate) 
moderate  
(0) 
moderate 
(mild–severe) 
Applesauce 
none  
(0) 
trace  
(0) 
mild  
(trace–moderate) 
Severe 
(moderate–severe) 
Severe 
(moderate–severe) 
Thin Liquid 
none 
(none–trace) 
none  
(0) 
mild  
(trace–moderate) 
mild  
(trace–moderate) 
moderate 
(trace–severe) 
Table 8. Average VAS ratings and median categorical ratings of residue and the lower and 
upper boundaries of ±1 standard deviation (SD) or interquartile range (IQR). 
 
 There were significant differences between none, trace, mild, moderate, and 
severe ratings for both VAS and categorical ratings of cracker and applesauce videos 
(p<0.0001). For VAS thin liquid ratings, there was no statistical difference between 
ratings of none–trace (p=0.659) and mild–moderate videos (p=0.582); all other 
comparisons were statistically different (p<0.0001). Similarly, categorical thin liquid 
ratings were not significantly different between videos with none and trace residue 
(p=0.196) and videos with mild and moderate residue (p=0.617). All other comparisons 
of cracker and applesauce categorical severities were statistically different (p<0.0001). 
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Figure 12 demonstrates the trends graphically and emphasizes the non-significant 
difference in thin liquid ratings on both VAS and categorical ratings. 
 
 
 
 
Figure 12. Average clinician ratings of cracker, applesauce, and thin liquid residue. VAS 
averages are represented with +1 standard deviation (SD). Categorical medians are 
represented with the interquartile range (IQR). 
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 Bolus Type 
 
 There was a significant difference between clusters of ratings within the same 
severity level but across different bolus types. “None: cracker” VAS ratings were 
significantly different than “none: applesauce” VAS ratings, which were significantly 
different than “none: thin liquid” VAS ratings (p=0.005). The same result held true for all 
other differences between bolus groups at all other severity levels, rated on the VAS: 
trace (p<0.001), mild (p=0.004), moderate (p<0.001), and severe (p<0.001). Pairwise 
comparisons are listed in Table 9. Figure 13 illustrates the significant differences between 
average VAS ratings for videos with moderate amounts of thin liquid, applesauce, and 
cracker residue.  
 
 
Figure 13. Clinician averages of VAS ratings for videos with moderate residue from thin 
liquid, applesauce, and cracker boluses. Error bars represent +1 standard deviation and 
each x represents the average of the 4 expert’s ratings on the same videos. *All significantly 
different at p<0.001. 
* 
* 
* 
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 With categorical ratings, all severity levels were significantly different between 
bolus types (p<0.001) except for mild videos, which were not statistically different 
between cracker, applesauce, and thin liquid ratings (p=0.113). Therefore, it seems as if 
bolus type influences ratings and, accordingly, residue severity should be rated 
individually for different bolus consistencies.  
 
Bolus Type Comparisons (VAS Ratings) 
 None Trace Mild Moderate Severe 
Main Effect p=0.005 p<0.0001 p=0.004 p<0.0001 p<0.0001 
Pairwise: 
Cracker – Applesauce 
p=0.079 p=0.686 p=0.037 p<0.0001 p<0.0001 
Pairwise: 
Applesauce – Thin Liquid 
p=0.005 p<0.0001 p=0.004 p<0.0001 p<0.0001 
Pairwise: 
Cracker – Thin Liquid 
p=1.0 p<0.0001 p=1.0 p<0.0001 p<0.0001 
 
Bolus Type Comparisons (Categorical Ratings) 
 None Trace Mild Moderate Severe 
Main Effect p<0.0001 p<0.0001 p=0.113 p<0.0001 p<0.0001 
Pairwise: 
Cracker – Applesauce 
p=0.042 p=0.008 - p<0.0001 p<0.0001 
Pairwise: 
Applesauce – Thin Liquid 
p<0.0001 p<0.0001 - p<0.0001 p<0.0001 
Pairwise: 
Cracker – Thin Liquid 
p=0.001 p<0.0001 - p<0.0001 p<0.0001 
 
Table 9. Comparison of severity levels for each bolus type. VAS comparisons are listed in 
the top box and categorical comparisons are listed in the bottom box. The main effect is 
listed and, if significant, the significance levels of pairwise comparisons are listed (adjusted 
with Bonferroni). P-values in bold were considered to be significant. 
 
 Clinical Significance 
 The clusters of residue ratings were investigated for clinical meaningfulness using 
quality of life and diet data associated with each video. The median and mean quality of 
life score of the patients in the sample were 3 and 3.2, respectively (DHI: 1 normal to 7 
  
75
severe). The median and mean diet score were 5 and 4.26, respectively (FOIS: 7 normal 
to 1 strict NPO). The median and mean PAS score were 1 and 1.8, respectively (PAS: 1 
normal to 8 silent aspiration).  
 Relationships between categorical ratings and clinical variables 
 Figure 14 demonstrates the trends in the clinical data according to severity level. 
There was no significant relationship between all categorical ratings and patient-
reported quality of life (DHI, p=0.475) or clinician-assessed diet levels (FOIS, p=0.359). 
The FOIS score appeared to slightly increase toward the worse end with residue severity, 
but not significantly. There was a significant relationship between the 5 severity levels of 
residue and higher (worse) PAS scores (p=0.046). In post hoc testing, none of the 
pairwise comparisons maintained significance. It is possible to have a significant test for 
the entire model but none of the pairwise combinations are significantly different. 
Because of the clinical implications, further post hoc testing was carried out to investigate 
which levels of severity (as rated by the clinicians) were significantly associated with a 
worse PAS score.  
 Adjusted Bonferroni post hoc testing revealed several significant differences in 
PAS scores when the severity levels were grouped together. There were significant 
differences in PAS scores with the following groupings: none/trace residue combined 
versus severe (p=0.04), none/trace/mild videos combined versus severe (p=0.037), and 
none/trace/mild/moderate videos combined versus severe (p=0.0005). All other 
comparisons of groupings did not reach significance. A risk ratio was calculated and 
patients judged to have a severe overall amount of residue had 4.4 times the risk of 
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aspiration than a patient with no, trace, mild, or moderate residue, although this was not 
significant (95% confidence interval 0.72–26.5). 
 Relationships between VAS ratings and clinical variables 
 The same comparisons were made, but now with the VAS ratings. The results 
echo the categorical findings. There was no significant relationship between VAS ratings 
of residue and patient-reported quality of life (DHI, Spearman’s r=-0.091, p=0.681) or 
clinician-assessed diet levels (FOIS, Spearman’s r=0.275, p=0.10). There was a moderate 
and significant relationship between worse PAS scores and an increase in residue ratings 
(Spearman’s r=0.494, p=0.001). Figure 14 displays the regression lines for the continuous 
VAS variable and the other ordinal variables. There is no significant trend in the 
regression lines of the FOIS and DHI data, but a significant and moderate trend in the 
PAS data. 
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Figure 14. Median diet (FOIS), quality of life (DHI), and Penetration-Aspiration Scale 
(PAS) scores grouped according to residue severity judged categorically (error bars 
represent ±1 standard deviation). The correlation lines represent the relationship between 
the 3 same variables and VAS ratings. *Only the PAS scores and categorical/VAS ratings 
were significantly correlated. 
* 
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CHAPTER FIVE: 
Dissertation Discussion  
Abstract 
This chapter discusses the dissertation results along with their implications and 
limitations. The reliability findings are reassuring that, even without training, clinician 
ratings were consistent between and within themselves and were very similar to expert 
ratings. The subsequent analyses demonstrated that residue ratings sit along an uneven 
continuum and thus need to be measured more flexibly, a critical finding for future 
research and clinical purposes. Lastly, the clinical significance of the groupings, or 
‘clusters,’ of ratings along the uneven continuum confirm that residue severity was 
associated with penetration and aspiration, but better scales are needed to measure 
clinical factors like diet and quality of life, as the present ones were not correlated with 
residue severity. 
 
 
5.1 Discussion 
 The field of dysphagia is beset by a problem of measuring the amount of 
pharyngeal residue on flexible endoscopic evaluation of swallowing (FEES). The unclear 
variable of ‘amount’ is undoubtedly related to a measurement problem. The goal of this 
body of work was to better understand perceptual judgments of residue and the influence 
of a visual analog scale (VAS) versus a categorical scale on clinician ratings. 
 As explained in the methodology described in Chapter 3, this dissertation was a 
prospective design that collected, at two different time points, clinician ratings of the 
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overall amount of residue on FEES. Thirty-three clinicians participated and rated a range 
of amounts of residue seen on a total of 81 videos consisting of cracker, applesauce, and 
thin liquid presentations. Each clinician rated every video twice resulting in 2,673 VAS 
ratings and 2,673 categorical scale ratings. Three research questions were investigated, 
discussed below along with the interpretation of the results and relevance to the field of 
deglutology. 
5.2a. Reliability of Residue Ratings and Expert Ratings 
 Reliability 
 Both the VAS and categorical ratings had acceptable inter-rater reliability 
(ICC>0.7). It was hypothesized that categorical ratings would have demonstrated an 
ICC<0.7 because of the previously reported variability in categorical ratings of residue on 
FEES (Kelly et al., 2006; Pisegna & Langmore, 2016; Kaneoka et al., 2013). Yet the 
current study demonstrated high agreement among clinicians (ICC 0.81–0.82). This is 
even more interesting considering that no training was provided and there was a wide 
range of residue severities presented across 75 videos. In a different study with 
comparable design, raters were not given any training or prompting, and the reported 
reliability (ICC) was about 0.60–0.61 (Kaneoka et al., 2013), much lower than the ICCs 
of 0.81–0.82 in the present study. Further, in that study, after providing 3 hours of training 
for categorical ratings of residue on FEES, the reliability between 4 raters across 63 
videos increased to only ICC of 0.81 and 0.80 in two respective sessions (Kaneoka et al., 
2013), almost equal to the present study consisting of an untrained, a much larger, and a 
more diverse group of clinicians.  
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 One possible explanation for the same level agreement with much less training is 
that clinicians in the present study were given a prompt of when to judge the residue: at 
any time immediately after the first swallow but before the clearing swallows. This 
structure could have increased the reliability. This is a valuable finding: if timing of 
scoring is controlled for, clinicians can be reliable. Kaneoka et al. (2013) did not 
distinguish a particular scoring time and included clearing swallows in the untrained 
overall impression. Clearing swallows appear to be an important variable in residue 
ratings that add a seemingly influential factor into residue judgment. Only 1 out of the 9 
reviewed scales (listed in Chapter 2) indicated a scoring time. Another reason for high 
inter-rater reliability on categorical ratings could be that 5 categories, rather than 7, 
created greater chance agreement because there were fewer choices. However, this does 
not explain the high VAS reliability. A final consideration regarding the high inter-rater 
reliability on both the categorical and VAS rating is that other factors like rating location 
of residue were not reported, which likely increased the chances of clinician agreement 
on a more global impression. Perhaps, then, cueing clinicians when to judge overall 
amount of residue is more important for agreement than training clinicians how to judge 
residue.  
 The inter-rater reliability results also suggest that bolus consistency makes a 
difference, given the lower agreement of ratings of thin liquid residue, although the 
reliability was still acceptable. While cracker and applesauce reliability coefficients 
ranged from an ICC of 0.8–0.9, the thin liquid reliability was about 0.7–0.8. Thin liquid 
fluidity makes it difficult to assess, and is likely a reason why some scales for residue 
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ratings have not used liquids in their development (Neubauer et al., 2016). Thin liquid 
can also be somewhat transparent or blend in with pre-existing secretions, making it 
difficult to detect and variable from clinician to clinician. These are a few reasons why 
the thin liquid ratings may have demonstrated a slightly lower level of reliability. Some 
solutions to account for these limitations might be to report the worst location of thin 
liquid in addition to amount (to account for the fluidity), or to use a bolus that is more 
easily visualized like white food dye instead of the 2 drops of green food dye used in this 
study, which could have been too diluted. Such a small difference in reliability may not 
have much impact on clinical practice, but for research purposes, the lower reliability on 
thin liquid boluses should be considered if agreement is an important variable. A possible 
take away from these results is to rate thin liquids only for penetration and aspiration and 
judge residue via solids only. In this light, an interesting future question would be: if a 
patient demonstrates residue on thin liquids, do they also demonstrate residue on solids? 
An affirmative answer to this question would enable avoiding the lower reliability on thin 
liquid residue and optimizing impressions using the more reliable ratings of solid residue 
alone. 
 Interestingly, the VAS ratings had better within-clinician agreement (intra-rater 
reliability) than the categorical ratings. Within-clinician agreement on VAS ratings was 
determined to be ‘excellent’ (rc=0.9) whereas agreement on categorical ratings was 
determined to be ‘good’ (k=0.78). This is an intriguing finding considering that there are 
countless choices on a 100-mm line and that the ratings of the same video were 
performed an average of 2 weeks apart. Further, there were no tick marks on the VAS line 
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that could have biased placement. In a survey completed after the study, many clinicians 
commented that they felt their ratings on the VAS were unreliable, “It was harder to tell if 
I was being consistent,” “Difficult to replicate,” “Not sure if I was consistent,” “May not 
be as consistent each time.” However, the data demonstrated the opposite. Clinicians 
were very consistent using the VAS. About 96.9% of the repeated VAS ratings were 
within 25mm of the first rating, and 66.7% were within 10mm of the first rating. In fact, 
16 clinicians were surprisingly within 1mm of their first rating. These results suggest that 
clinicians were indeed consistent when scoring on the VAS, more so than on a categorical 
scale. It could be that with the greater precision allowed in rating amount on a VAS, 
clinicians were able to be more consistent in their ratings. Previous research on VAS 
measurement agrees; VAS ratings allow for more freedom in rating slight gradations, 
which results in better reliability (Pfennings, Cohen, & van der Ploeg, 1995; Holmes & 
Dickerson, 1987; Brunier & Graydon, 1996).  
 Another point of discussion regarding high intra-rater reliability is that without 
any training or operational definitions, each clinician invariably had a means of 
interpretation in their mind, which likely played a strong role in the consistency of 
ratings. This ‘internalized scale’ may have contributed to the high and steady within-
clinician reliability that is reported here and elsewhere. Other studies of FEES residue 
have found similar results, i.e. that intra-rater reliability was higher than inter-rater 
reliability of residue ratings on a categorical scale (Kaneoka et al., 2013; Tohara et al., 
2010; Kelly et al., 2006). The literature also reports that intra-rater reliability on 
categorical ratings remains high but unchanged over time, even with training or repeated 
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exposure (Neubauer et al., 2015; Kaneoka et al., 2013; Tohara et al., 2010). Therefore, a 
clinician’s internalized scale appears to be a strong factor that is difficult to influence, 
even with training.  
 Finally, reliability is important for ensuring that patients receive consistent 
diagnoses and treatment regardless of which clinician is treating them. Agreement 
between clinicians is important (inter-rater reliability) but so is agreement within a 
clinician (intra-rater reliability). If one clinician is treating a patient over a course of time, 
then consistency within that clinician is most important and the VAS is likely going to be 
the best measurement to ensure high consistency of residue ratings on FEES. Previous 
studies support the use of VAS over categorical ratings for reasons other than higher 
reliability, such as greater statistical power and a ratio-based method less cumbersome 
than others like direct magnitude estimation (Baylis et al., 2015).  
 The limitations of the reliability testing in this study were that only two exposures 
were provided, when ideally intra-rater reliability would include multiple exposures 
(Portney & Watkins, 2009). Even though an average of 2 weeks was provided between 
ratings and audio and other identifiers were removed from the videos, it is possible that 
clinicians recognized videos and their assigned rating, enabling higher clinician 
agreement. In the same way, the small groups could have created a setting where 
clinicians looked at each other’s ratings, although clinicians were instructed to rate 
independently, discussion was not allowed, and the sessions were closely monitored. 
Based on the results from this body of work, between- and within-clinician agreement on 
the VAS were acceptable and slightly higher than categorical reliability measures. 
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Training clinician judgment of overall amount of residue does not seem necessary to 
improve reliability if judgments are made immediately after the first swallow. 
 
 Expert Ratings 
 This dissertation faced a dauntingly simple question that still lurks unanswered in 
the shadows of the results: how much residue is there? While it was not possible to 
determine how much residue was truly present in the videos, estimates can be made. A 
substitute gold standard, or “reference standard,” is considered an acceptable criterion in 
the absence of a true calculation of the overall amount of residue (Portney & Watkins, 
2009, p. 103; Sackman, 1975). Using a consensus of experts as a ‘gold standard’ is 
common in judgment studies of non-verbal behavior where there is also an absence of a 
known truth (Rosenthal, 2008; 1966). In fact, multiple studies in the field of deglutology 
have used experts as the reference standard in either a Delphi, a consensus, or an 
averaging method (Hutcheson et al., 2016; Neubauer et al., 2015; Kaneoka et al., 2013; 
Martin-Harris et al., 2008). However, these studies only report reliability ratings between 
the experts, likely due to the inability to do true sensitivity testing with their reported 
methodologies. 
 Curiously, there has been no published study that directly compares expert ratings 
to others. Therefore, this dissertation investigated expert ratings of residue on FEES. The 
literature has assumed that there is something different or special about expert ratings 
without any empirical support. The current investigation classified experts as clinicians 
with 15 or more years of experience performing and interpreting FEES. The expert VAS 
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ratings of pharyngeal residue on FEES did not significantly differ from proficient or 
novice clinician ratings for any severity of applesauce and cracker boluses. This 
contradicts the hypothesis that years of FEES experience influences residue ratings. 
Based on the present results, one should not expect expert ratings of global residue 
amount to be different from other clinician’s ratings when considered in the aggregate.  
 The lack of difference between expert, proficient, and novice clinician ratings of 
residue is a novel finding. But if experts are not unique, then the question remains as to 
what to use as the reference standard to represent how much residue is present. 
Borrowing research from the field of non-verbal behavior seems appropriate as similar 
challenges are faced in measuring observations, like how much happiness is expressed. 
What is striking is how similar that problem is to rating residue: dynamic events 
characterized by a swath of variables. Research with nonverbal behavior has shown that 
humans are perceptually very good at accurately discerning and synthesizing complex 
cues and perceiving in a gestalt-like manner (Tickle-Degnen & Rosenthal, 1990; 
Bernieri, 1988A; Bernieri et al., 1988B). A 2005 study used video clips of people with 
Parkinson’s disease to rate expressive behavior (Lyons & Tickle-Degnen, 2005). Results 
showed that the mean of raters’ impressions reliably and accurately measured expressive 
behavior of persons with Parkinson’ disease in 30-second clips of videos. In line with 
those conclusions, this body of work assumes that, one, the average of clinician ratings of 
residue will be near the truth, and two, expert ratings are not disparate from other 
clinicians’ ratings. When future studies are looking to classify how much residue is 
present, it will be important to have a large group of clinicians rate the videos with an 
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indicator of when to score.  
 This dissertation concludes that an average of an adequately-powered sample of 
clinicians could be used as a reference standard, assuming that a gestalt rating judged 
from a video clip will be near the truth (Rosenthal, 2008; Rosenthal, 1966). Some may 
choose to continue to use experts as the reference standard, given their experience with 
other refined clinical decision making skills like management of residue and diet 
recommendations. It would be interesting to see if an even-more specialized group with 
more than 20 or 25 years’ experience would change the findings, but that may not be 
possible seeing as FEES was only created about 29 years ago in 1988 (Langmore, 1988). 
In summary, it is recommended to use an average of a variety of clinicians to determine a 
reference standard of residue. This is a reasonable conclusion based on this dissertation’s 
findings, until other more valid measures of the amount of residue present can be 
determined. The final chapter of this body of work will propose new objective measures 
to quantify how much residue is actually present via a 2-dimensional calculation.  
5.2b. Rethinking the Dimensions of Residue 
 The second research question asked how the VAS and categorical scales would 
correlate. The findings revealed that VAS ratings correlated strongly and significantly 
with categorical ratings, confirming preliminary findings from other datasets (Pisegna & 
Langmore, 2015). The strong correlations also highlighted that as VAS ratings of residue 
increased, so did categorical ratings of thin liquid, applesauce, and cracker residue. But 
the relationship was not a 1:1 increase, raising a question about the psychometric 
differences between the two rating methods. To investigate the measurement dimensions 
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of desired variables, analyses originally proposed by Stevens (1975) were undertaken in 
the same fashion as multiple other studies. For example, researchers have looked at the 
psychometric properties of measuring voice quality (Toner & Emanuel, 1989, Zraick & 
Liss, 2000A), stuttering (Schiavetti et al., 1983), and speech naturalness in amyotrophic 
lateral sclerosis (Southwood, 1996; Southwood & Weismer, 1993). The analysis 
established by Stevens (1975) permits a determination between a metathetic dimension, 
a property that changes in quality and not quantity along an equally-spaced continuum, 
and a prothetic dimension, a property that changes in degrees of quantity or magnitude in 
unequal intervals.  
 The plots and quadratic modeling of this dissertation study’s data demonstrated 
that the continua of residue ratings are not evenly-spaced and linear, but rather 
curvilinear. The curvilinear models accounted for a significantly greater proportion of the 
variance in predicting clinician ratings of residue. The results suggest that residue exists 
in a prothetic dimension: as residue increases, it changes unevenly in quantity, not 
quality. Figures 15A, 15B, and 15C illustrate the proposed models and the conversion 
between VAS and categorical ratings along the uneven severity spectrum. In each figure, 
there are proposed zones for severity interpretations for each bolus type within the shaded 
grey boundaries (representing the upper threshold of +1 standard deviation of all rater’s 
impressions). Readers should be cautioned to avoid strict interpretation of the boundaries, 
as overlap is a critical aspect. 
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(A)  
(B)  
(C)  
Figure 15. Three curvilinear models for (A) cracker, (B) applesauce, (C) thin liquid residue 
ratings to represent the relationship between visual analog scale (VAS) ratings and 
categorical ratings. Each blue circle is a data point and the 95% confidence interval of the 
model is indicated by a dotted blue line above and below the regression line. The grey lines 
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are the upper thresholds of +1 standard deviation from all clinician ratings of that cluster of 
videos. 
 It is important for clinicians and researchers to appreciate that the categories are 
uneven. This may seem obvious, but it is a critical finding. In accordance with the 
Stevens methodology of measurement dimensions (1975), because the data is fit best 
with a curvilinear model, residue should not be measured in equally-spaced intervals 
(mild/moderate/severe), but rather in a non-linear fashion (on a ratio scale such as a 
VAS).  
 Previously published scales for rating pharyngeal residue on FEES are not widely 
used, perhaps because the scales used to measure residue have been inappropriate 
mismatch between the measure and concept. An easy, reliable, and valid scale is sorely 
needed given the variability in categorical ratings of amount of residue (Kelly et al., 
2006; Pisegna & Langmore, 2016). It is hoped that this body of work will assist scale 
development by providing insight into measurement dimensions. Until now, pharyngeal 
residue has not been examined in this light. The only consideration of a scale truly based 
on a ratio measurement is an unpublished dissertation investigation involving ratings of 
residue in the neopharynx of laryngectomy patients. In that study, three raters ranked the 
amount of residue on a VAS with exemplar pictures to demonstrate the none and severe 
anchors (M. Coffey, personal communication, April 4, 2016). It would be of great interest 
if the results of that study’s VAS ratings fit unequal spacing, which would corroborate 
this dissertation’s findings. That author verbally reported high intra-rater reliability on the 
VAS, which also supports the present findings (M. Coffey, personal communication, 
April 4, 2016). 
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 The results of the present research investigation should serve as a starting point 
for further discussion of how residue is best measured to represent this important 
outcome of swallowing disorders. Multiple limitations must be mentioned. First, theories 
from other fields (psychology, voice) may not directly carry over into the field of 
deglutology. Second, this study used VAS ratings, not formal direct magnitude estimation 
(DME) ratings, and the results may be skewed due to the slight differences in these 
measurement techniques. However, several previous studies found DME and VAS ratings 
to be comparable in determining dimensions of measurement (Cheng, 2006; Yiu & Ng, 
2004; Baylis et al., 2015). Finally, 5 examples of each type of severity may not have been 
enough to adequately represent the range of residue severities, skewing the impressions 
one way or another depending on the video. But the FEES videos were a relatively large 
group of stimuli: 75 videos consisting of 25 varying severities for 3 bolus types. The 
statistical analyses were adequately powered, which further support the result: residue has 
a strong curvilinear quality and measurement scales should account for this property. 
5.2c. Determining Meaningful Clusters of Ratings  
 
 The final research question aimed to investigate the ratings from the curvilinear 
model. It asked: do the ratings of residue cluster in certain areas, how do VAS and 
categorical clusters compare, and is there any clinical significance to the clusters? In 
brief, clusters of ratings were noticed and the clinicians were keen at distinguishing levels 
of residue severity, unprompted and untrained. The interesting trends are more fully 
described, below, under the following headings: clusters, halo effect, bolus type, and 
clinical significance. 
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 Clusters 
 The VAS and categorical ratings demonstrated ‘clusters’ or trends in the ratings 
that support the theory of curvilinear measurement properties of residue. Two noteworthy 
patterns appeared in the clusters. One, clusters of residue ratings existed in unequal 
intervals, a confirmatory finding given the results in the aforementioned research 
question. The VAS and categorical ratings for none, trace, and mild videos existed in 
relatively tight clusters with small standard deviations or interquartile ranges (see left side 
of Figure 16). But as the amount of residue increased, so did the range of clinician 
impressions. Intriguingly, clinician agreement was still acceptable despite the larger range 
of ratings. This suggests that the demonstrated spread was not clinician variability, but 
rather a larger range of residue presentations within the more severe categories.  
 
 
 
 
 
 
 
 
 
Figure 16. A plot of VAS ratings of no residue, left of the dotted line, and severe residue, 
right of the dotted line, for cracker, applesauce, and thin liquid residue ratings. An X 
represents the average of expert raters and the error bars are ±1 standard deviation of that 
video’s ratings. All ratings were significantly different between the 3 bolus types. 
Average VAS Ratings 
Video 
Number 
Ratings of  
No Residue 
Ratings of 
Severe Residue 
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 This finding supports the theory that residue is prothetic in nature; ratings 
increased in magnitude in an additive manner rather than increasing in a substitutive 
manner (metathetic) (Stevens, 1975). Just as the field of voice adopted a VAS rating 
method to more appropriately measure the perception of vocal quality (Eadie & Doyle, 
2002; Zraick et al., 2011), it appears as if the field of deglutology should adopt a VAS to 
more appropriately measure the perception of amount of residue on FEES.  
 Two, there was overlap in almost all of the ratings, both VAS and categorical. 
This likely represents a need to rate residue in fine gradations. The feedback from 
clinicians regarding the categories was clear. They desired options for mild-moderate and 
moderate-severe on the categorical ratings: “wanted mild-mod and mod-sev,” “wish I 
could choose from in-between boxes.” The use of five categories was a limitation in the 
present study. The choice to use five categories was based on a plethora of extant scales 
that only include 5 categories (i.e., Kelly et al., 2006). If categorical ratings are used in 
future studies, they should include more categories like mild-moderate and moderate-
severe to allow for more precision in the categorical ratings. Surprisingly, the VAS ratings 
did not demonstrate the expected clusters in the mild-moderate or moderate-severe ranges 
(Figure 17) that the clinicians desired on the categorical scale. The relatively specific 
placement of ratings supports the use of a VAS to accommodate the clinicians’ 
demonstrated desire for precision when rating residue. 
Moving forward, if visual analog scales are considered, tick marks should not be 
used. Previous studies have documented a bias effect when tick marks are placed on a 
VAS such that raters’ perceptions are biased towards equally-spaced intervals and raters  
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are more likely to mark directly at the site of the tick marks (Matejka et al., 2016). 
 
Figure 17. Average of 33 clinicians’ VAS ratings of cracker residue across all presented 
cracker videos (n=25). Error bars represent ±1 standard deviation of each video’s ratings. 
 
 Halo Effect 
 On VAS ratings, a halo effect was seen across all ratings. This was also observed 
on the categorical ratings but not to the same degree. A halo effect is a large empty zone 
on either of the extreme ends of a scale, which creates an empty halo appearance 
representing the tendency of raters to avoid the extremes of a rating scale, usually a 
carryover effect from repeated ratings (Carlsson 1983; Downie et al., 1978). In this study, 
the halo effect was prominently seen on the right side of the scales, at the “severe” end 
(Figure 12). The reason for the halo effect in this study may have been that clinicians 
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were unsure of what the most severe videos would look like, and they were saving the 
severe rating for a potentially worse video. This is a likely explanation given that 
clinicians were not told how many videos of each severity were presented. It could also 
be an effect from repeated ratings, although VAS and categorical ratings were 
randomized within each session to reduce this effect and all ratings were made on a new 
sheet of paper. Further, clinicians may have defined a very severe rating as including 
factors other than the overall amount of residue, such as severe aspiration, which was 
only seen in one video (subsequently rated an average of 82.9mm of the VAS and an 
average of “severe” on the categorical scale). On one hand, this finding lends weight to 
other types of scales that provide visual anchors for the extreme ratings with examples of 
what severe looks like (Neubauer et al., 2015; M. Coffey, personal communication, April 
4, 2016). On the other hand, if scales do not provide examples or definitions of what 
defines severe, then they should take into account that raters may be hesitant to rate at the 
extreme anchor of severe. This would be a drawback to one of the newer scales in the 
field for rating residue on MBS evaluations (Hutcheson et al., 2016). The authors of that 
scale define “near complete residue” as >90%, and, despite differences in evaluation type 
and rating method, the results of present study suggest that raters would very rarely rate 
residue at that extreme. 
 Bolus Type 
 There was a significant difference between clusters of ratings and bolus type, 
meaning “none: cracker” ratings were significantly different than “none: applesauce” 
ratings were significantly different than “none: thin liquid” ratings. This held true across 
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both VAS and categorical ratings. The only exception was that all categorical ratings of 
mild severity were the same between cracker, applesauce, and thin liquid ratings. Overall, 
it seems as if bolus type influences ratings and accordingly, residue severity should be 
rated individually for different bolus types.  
 Why would a moderate amount of applesauce differ from a moderate amount of 
cracker, for instance? The answer probably lies in the location of the residue and in the 
viscosity of the bolus. The ‘location’ of residue was not specifically tracked but rather 
determined by the penetration-aspiration scale score as far as ‘in’ or ‘outside’ of the 
laryngeal vestibule (PAS; Rosenbek et al., 1996), indicating to which level of the airway 
the bolus penetrated. Previous research has suggested that residue in lower areas of the 
pharynx puts patients at a higher risk for aspiration (Pisegna, Kaneoka, & Langmore, 
2016; Han et al., 2001), although another study using MBS videos found the valleculae to 
be associated with a higher aspiration risk than the pyriform sinuses (Molfenter & Steele, 
2013). These results appear to depend on consistency, as thin liquid tends to collect in the 
lower pharynx. A speck of residue on the vocal folds may carry much more significance 
than a moderate amount of residue in the valleculae. In pilot work for this dissertation, 
there were instances where residue in only one zone alone was rated severe while diffuse 
residue in all 3 zones was rated as mild (Pisegna, Kaneoka, & Langmore, 2016).  
 There appears to have been an incidental error in an uneven distribution of PAS 
scores across the videos for this dissertation. The PAS was an uncontrolled variable and 
even though the PAS scores were not significantly different between cracker, applesauce, 
and thin liquid videos (p=0.161), there was not as wide a clinical representation of PAS 
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scores on the cracker videos (range 1–3) as there was on the applesauce (range 1–7) or 
thin liquid videos (range 1–6). If clinicians were incorporating location of residue and/or 
aspiration of the bolus into their ratings, then the differences in PAS across consistencies 
likely influenced the results. This body of work did not aim to investigate location of 
residue but it is surmised that clinicians were incorporating severity of location into their 
overall impressions (for instance one clinician commented, “depending on 
location=higher risk of aspiration”).  
 In the same way, the viscosity of the bolus might have played a factor in the 
ratings. Masticated solids, such as cracker, clump together and often collect in the pocket 
of the valleculae in contrast to thin liquids that are fluid and susceptible to spilling into 
lower areas. Thin liquids can easily flow into the airway, but can also be easily coughed 
up. Thicker fluids and solids are not as easily ejected from the airway, thus a concern for 
choking or airway blockage. Perhaps this is one of the reasons why the thin liquid ratings 
demonstrated less severe and less reliable ratings. It is postulated that a previous study 
did not find a relationship between residue severity and PAS scores because different 
types of bolus consistencies were presented together, and high PAS scores on small 
residue amounts of thin liquid could have skewed the analyses (Pisegna, Kaneoka, & 
Langmore, 2016). As previously stated, it is not possible to know how the clinicians 
defined their ratings, but the results of this study suggest that ratings differ depending on 
the bolus type. The clusters of residue ratings were different depending on the bolus type 
and the thresholds for cracker, applesauce, and thin liquid clusters were at different cut 
points (Figure 12). Future rating scales should take this into account. 
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 Clinical Significance of the Clusters 
 There was a significant relationship between worse penetration-aspiration scale 
(PAS) scores and an increase in residue ratings. Both the categorical and VAS ratings 
demonstrated a significant association between residue severity and PAS. It is not 
possible to parse apart whether clinicians made residue ratings more severe because of a 
worse PAS score or if larger amounts of residue led to a worse PAS score. A useful 
follow-up question would have been: “what did you include in your overall impression of 
residue?” In general, the results of this study demonstrated that there was a relationship 
between residue ratings and penetration or aspiration of the bolus. A video with a severe 
overall amount of residue had 4.4 times the risk of aspirating in that video than a patient 
with no, trace, mild, or moderate residue. On a VAS, a rating greater than the average of 
about 70mm for cracker, 85mm for applesauce, and 54mm for thin liquid would indicate 
the same risk. Future scales would be wise to incorporate the PAS into the scale or 
include similar supplementary information.  
 The ‘clusters’ of ratings were investigated for other forms of clinical significance. 
There was no relationship between residue ratings and patient-reported quality of life, as 
measured on the Dysphagia Handicap Index (DHI). The DHI has undergone validation by 
the authors (Silbergleit et al., 2012), but the lack of significant association in the current 
study is concerning. The first theory to explain the lack of association is that the observed 
signs of dysphagia do not always match the patient-reported symptoms of dysphagia. 
Some patients in this study had reflux symptoms from which they experienced a referred 
sensation of food sticking in their throat (rated ‘severe’ on the DHI), when there was no 
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residue visualized on the FEES video. In contrast, some patients had completed treatment 
for head/neck cancer and rated their swallowing problem as mild despite ample residue 
seen on the FEES video. For these patients, their swallowing problem may have been 
acceptable, knowing that they had just been treated for cancer. While this could not be 
formally studied due to multiple co-morbidities and small sample sizes upon stratification 
of the dataset, this is the postulated explanation for a lack of correlation. Another thought 
is that it was unreasonable to expect the clinical measure of residue to correlate to patient 
reports of quality of life because quality of life is very much a multifactorial experience 
that would not likely correlate strongly with any single clinical factor. Moving forward, 
population-specific quality of life forms or a more specific item-by-item assessment of 
symptoms are indicated to prevent poor detection of dysphagia symptoms via patient 
report.  
 The second explanation is that as a tool, the DHI 7-point Likert scale does not 
adequately capture the swallowing problem via patient report. This is a reasonable 
conclusion considering that other evidence strongly suggests that there is a relationship 
between residue and decreased quality of life. Studies have shown that patients truly are 
bothered by residue, even more so than other health outcomes like aspiration or 
pneumonia (Martino et al., 2008; McHorney et al., 2002). The DHI scale was validated 
on a mixed group of persons with dysphagia (head/neck cancer, reflux, stroke, etc.; 
Silbergleit et al., 2012), similar to this dissertation. However, the original article 
compared the overall DHI score to MBS evaluations of only 4 people with a moderate 
dysphagia and 8 people with a severe dysphagia. This is not nearly enough to represent a 
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wide range of patients, and it raises questions about the validity of the scale.  
 An intriguing article by Speyer and colleagues (2014) described a systematic 
review of all functional health status questionnaires. The authors subsequently excluded 
the DHI due to determination that it was a ‘health-related’ questionnaire. Their 
conclusion was that there are currently no scales with appropriate psychometrics to assess 
the interplay between subjective well-being and dysphagia. The authors made a point to 
distinguish between ‘health-related’ questionnaires and ‘functional health status’ 
questionnaires, the latter focusing on causal relationships and other non-health related 
aspects of life like cultural influences and characteristics of the individual and 
environment (Ferrans et al., 2005). It is possible that the DHI swallowing severity score 
does not encapsulate the overall well-being of a wide range of persons with dysphagia. 
This body of work has proposed a conceptual model in Chapter 1 that involves not only 
residue and other domains of dysphagia outcomes, but also other factors involved in 
quality of life, as recommended by the authors of similar conceptual models (Ferrans et 
al., 2005; Wilson & Cleary, 1995). Until an excellent quality of life scale is developed for 
the generalized population of anyone with dysphagia, it is prudent to use the best 
validated quality of life scales for specific populations, such as the MD Anderson 
Dysphagia Inventory for head/neck cancer patients (Chen et al., 2001). 
 This dissertation also found no relationship between clinician-determined diet 
levels and residue ratings. It has been well documented that when patients experience 
residue from dysphagia, their diet changes lead to food avoidance, malnutrition, or both 
(Meyers et al., 2016; Lin et al., 2005; Foley et al., 2009; List et al., 1990; Martino et al., 
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2005; McHorney et al., 2002). Therefore, the results of this study point yet again to a 
measurement problem. The tool used in this dissertation to measure diet was the 
Functional Oral Intake Scale, an ordinal 7-point scale developed for stroke patients 
(FOIS; Crary, Carnaby-Mann, & Groher, 2007). The misapplication of this scale to a 
mixed sample may be one of the reasons why no association was detected between 
residue ratings and diet. Too frequently scales are used regardless of the type of 
population and validation evidence. The present negative results support the idea scales 
should not and cannot be applied to populations on which the scale has not been 
validated, especially in dysphagia patients.  
 What is the best way, then, to measure diet in patients with dysphagia? Using 
population-specific scales is difficult, clinically, and also not always possible due to a 
lack of scales for each population. For the stroke population, the FOIS would be 
appropriate. One study used the FOIS as a screening tool to identify patients with a 
normal oral intake (Miles et al., 2016). While the scale was not developed as a screening 
tool and it lacks psychometric verification of such application, it is an interesting idea in 
the absence other better options. For the head/neck cancer population, the Performance 
Status Scale (List, Ritter-Sterr, & Lansky, 1990) or Common Terminology Criteria for 
Adverse Events: Dysphagia Item (CTCAE) might be appropriate, but require more study. 
There is a diet scale called the Dysphagia Outcome and Severity Scale (DOSS) that is 
validated on a large mixed population, but it requires the use of an instrumental 
evaluation to determine the recommended diet level, not based on what the patient is 
currently taking (O’Neil et al., 1999). For the general population, the American Speech 
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Language and Hearing Association suggests National Outcome Measures (NOMS). 
Unfortunately, in order to be trained and use this 7-point scale rating diet and function, 
clinicians must be registered as a data collection site (http://www.asha.org/NOMS/How-
Medicare-Claims-based-Reporting-Relates-to-NOMS/). Until better scales are developed, 
clinicians should document descriptions of patient-reported diet along with comments 
regarding food avoidance, weight loss, and nutritional status to describe effects of the 
patient’s dysphagia. 
 Lastly, the lack of association between residue and diet levels brings into question 
the sensitivity of swallowing evaluations as they relate to the larger concept of diet status. 
FEES and MBS evaluations typically do not include an assessment of a full meal. It is 
possible that an assessment of a few trials of boluses like applesauce are an unrealistic 
snapshot of ability to functionally take a meal, let alone 3 meals per day. If a patient 
complains of hard or crunchy solids sticking in their throat, it is important to include such 
a bolus in realistic volumes as part of the assessment. Assessments could potentially be 
inadequate if they do not capture, or at least explain, the dysphagia. 
 In conclusion, the field is clearly limited in ways to measure quality of life and 
diet in persons with dysphagia. This is why it is critical to perform thorough interviews to 
assess for red flags reported by patients such as interference with family/friends, 
significant feeling of burden or depression, malnourishment, and others. Working hand in 
hand with other professionals such as nutritionists is another useful solution. Finally, 
researchers should think carefully about what diet scales are selected for outcomes 
measures, particularly the population to which they will be applied.  
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CHAPTER SIX: 
A Look to the Future and Conclusion 
 
Abstract 
The aim of this final chapter is to propose innovative ways to apply the dissertation 
findings. This chapter briefly describes two recent research projects that apply new 
applications for measuring pharyngeal residue on FEES. A conclusion follows to 
summarize this dissertation’s findings and potential contributions to the field of 
deglutology.  
 
6.1. Quantifying Residue on FEES: 
Correlation to Clinician Judgment 
 
 At the time of the design of this dissertation project, there was no known 
computerized method to measure residue on FEES. However, as happens with fast 
advancements in technology, some computerized techniques for measuring residue have 
been developed in the past few months. In efforts to evolve with the developments, this 
dissertation work adopted some of the advanced computerized methods and applied them 
to the dissertation data.  
 A pilot project was undertaken to use a novel method of quantifying residue 
digitally by determining the residue’s number of pixels (Figure 18). Images from the 
same FEES videos used for the dissertation study were uploaded to a specialized 
computerized program that performed automatic detection and segmentation of residue 
regions in one selected image frame per video. The number of pixels representing residue 
were compared to the number of pixels in the total measurement region of the two-
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dimensional pharyngeal space. This method is similar to that developed for outlining 
residue on MBS evaluations (Park et al., 2014; Pearson et al., 2013; Dyer, Leslie, & 
Drinnan, 2008). Only videos with visualization of at least 75% of each of the 3 identified 
zones were included in analyses. The boundaries of the 3 zones were based on a previous 
factor analysis study (Kaneoka et al., 2013). The sum of the outlined residue in all 3 
zones was used to represent the ‘overall’ residue amount. The ratios of the overall 
outlined residue to the total measurement region were compared to the dissertation’s 
results of clinicians’ perceptual ratings on the visual analog scale (VAS). Correlations 
were performed to determine the strength of the association between the percentage of 
outlined residue in the video view and clinician ratings on the VAS. 
 
Figure 18. An image of a computerized outline of cracker residue within three zones, 
outlined in yellow. The percentage of residue filling each zone is provided and an overall 
estimate of two-dimensional residue can be calculated by adding the three zones. 
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 Spearman correlations between the clinician VAS ratings and actual percent of 
residue filling the entire zone were high: cracker videos (n=11, r=0.963, p<0.0001), 
applesauce videos (n=17, r=0.971, p<0.0001), thin liquid (n=11, r=0.788, p=0.004).  
However, the relationship was largely ‘monotonic increasing’ as revealed by a Kendall 
Tau rank correlation statistic of 0.872 (a pair of variables consistently increasing and not 
decreasing). The clinician VAS ratings were always higher than the actual percent of 
residue calculated and the gap widened as the amount of residue increased. For cracker 
videos, the differences between clinician and computerized ratings of residue ranged 
from 1.3 (for no to trace residue) to 49.4 (for larger amounts of residue). For applesauce 
videos, the differences ranged from 1.2 to 59.2, and for thin liquid videos the differences 
ranged from 1.5 to 44.5 (Figure 19). Thin liquid videos did not demonstrate as strong a 
trend, an expected finding based on the variable results of thin liquid residue ratings from 
the dissertation work. 
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(A)   
(B)  
(C)  
Figure 19. Clinician visual analog scale ratings of overall percentage of residue on FEES (in 
red) compared to a two-dimensional computerized outline (in striped blue). The ratings of 
the three different bolus consistencies of (A) cracker, (B) applesauce, and (C) thin liquid are 
shown. 
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 When a clinician estimates the percent of residue throughout the pharyngeal and 
laryngeal regions, they may overestimate the two-dimensional percentage of the residue 
area and/or incorporate a judgment of clinical importance. This pilot project was an 
unexpected application of the dissertation findings, seeing as this software was not 
available at the onset of the dissertation study. However, research must evolve with 
technology and the application of the computerized software was a novel first step to 
quantify how much residue is seen on FEES. Other studies have shown that clinician 
impressions of residue are more severe on FEES when compared to videofluoroscopy 
(Pisegna & Langmore, 2016; Kelly et al., 2006, 2007; Rao et al., 2003). This study 
demonstrated that clinician impressions are more severe when compared to computerized 
outlines of residue on FEES.  
6.1a. Is This the New Gold Standard? 
 An interesting question is: if the computerized method is to serve as the new 
reference standard, how well do clinician ratings match to it? The pilot study described 
above illustrated the high correlation between clinician and computerized ratings, but to 
determine true accuracy, other analyses are more appropriate. Thus, the two-dimensional 
computerized outline was labeled as the ‘truth’ and clinician VAS ratings on each of the 
75 videos were considered correct if they were within ±20% of the computerized ratings. 
A receiver operating characteristics (ROC) curve was calculated to balance the sensitivity 
and specificity of the clinician VAS ratings when matched to the range of computerized 
ratings.  
 The ROC curve, in Figure 20, had an area under the curve of 0.8194, which was 
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significant at p<0.001 (95%CL: 0.62–1.0). A curve arching to the high left represents 
high sensitivity and high specificity, and a perfect test would have an area under the curve 
of 1.0. The diagonal reference line is the representation of poor sensitivity and specificity, 
no better than a flip of a coin. 
 
Figure 20. The receiver operating characteristics curve matching clinician ratings of residue 
from the 75 FEES videos to the computerized outline of residue. 
 
 This innovative method and novel finding is encouraging in at least two ways. 
One, if the computerized method can be standardized and validated, then it could serve as 
an objective reference standard for estimating the amount of residue present. Two, 
clinicians were accurate within 20% of the computerized value, lending legitimacy to the 
accuracy of the human eye. However, this computerized method requires further 
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development before it could be considered to be a true ‘gold’ standard. It is still only a 
two-dimensional estimate and Chapter 2 of this dissertation highlights the need to include 
depth as a factor in the endoscopic view. The human eye includes the depth dimension 
and this variable is unaccounted for in the two-dimensional computerized estimates. 
Therefore, until the computerized method can include an estimate for the depth of the 
amount of residue, then the human eye and an average of clinician ratings would be the 
best reference standard. 
 Other limitations are that clinicians probably incorporated other factors into their 
estimates, such as location of the bolus. What can likely be ruled out as a limitation is the 
factor of clinician experience. Since this dissertation work has shown that years of 
experience do not affect overall ratings of residue, it is unlikely that years of experience 
was a limiting factor in this study that used the same data set. Further investigation is 
needed, particularly to validate the computerized method and find a way to estimate 
depth of cavities on the endoscopic view. 
 
6.2. Quantifying Vallecular Residue on FEES and MBS Videos  
 A second pilot study incorporated the results of the dissertation in another attempt 
to computerize the measurements of pharyngeal residue. This investigation was also 
unexpected but a good example of the field’s need to evolve with technological advances. 
This pilot project used the same computer algorithm to outline residue, but with different 
videos to take advantage of the more developed measures on Modified Barium Swallow 
(MBS) evaluations. The rationale was that if MBS evaluations have a validated and 
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reliable method to quantify residue, then the amount of residue seen simultaneously on an 
endoscopic exam has to be the same amount. In this pilot study, the amount of residue in 
the valleculae was investigated using simultaneous studies: MBS and FEES done 
concurrently. They provide a unique opportunity to compare quantitative methods, 
knowing that what is visualized in each video represents the same exact residue.  
 A convenience sample of 8 simultaneous studies (FEES and MBS) was used for 
computerized analyses. Patients received a measured bolus of 5–15mL applesauce 
containing green food dye and 40% barium powder. For each MBS video, the 3 best 
frames representing the vallecular residue after the swallow of applesauce were selected. 
This is because the novel measures are developed for still images, not videos. A trained 
rater calculated the data for the Normalized Residue Ratio Scale of the valleculae 
(NRRSv) (Pearson et al., 2013), which factors in the patient’s size. A final measure was 
calculated as a new investigation to allow for scaling on the FEES: the length of the 
linear opening of the valleculae was determined in pixels using the penny from the MBS 
video as a scalar (Figure 21). For each FEES video, on each of the same exact 3 frames 
from the same time points used for the MBS data, a trained rater used edge-detection 
computer software to measure percentage of the valleculae filled with residue (Figure 
20). The length of the linear opening of the valleculae was also determined using 
proportional ratios from the size of the opening on the matching MBS image. The 
equation used for the scaling was an adapted version of that documented by Pearson et al. 
(2013), now using the vallecular opening as a scalar: 
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            Residue area in pixels           Residue area in pixels   
              Cavity area in pixels            (Vallecular opening)2 
 
 
Figure 21. At left: MBS outline and C2–C4 referent to determine the NRRSv (valleculae). 
At right: the same time point visualized on the FEES, with edge detection software to 
determine the percent of the valleculae filled with residue. The red line represents the 
measures taken for the opening of the valleculae. 
 
 The 8 simultaneous studies with varying degrees of residue were analyzed (24 
FEES images and 24 matched MBS images). The raw two-dimensional percentages 
(MBS vs. FEES) had a moderate correlation (r=0.537, p=0.007, r2=0.28). The NRRSv for 
MBS videos had a moderate-strong association with the raw two-dimensional percent-
filled measures from FEES videos (r=0.771, p<0.0001, r2=0.594). The area of the residue 
on the MBS video was scaled to the opening of the valleculae and this maintained a 
moderate correlation when compared to the area of the residue on the FEES video, scaled 
to the endoscopic view of the opening of the valleculae (r=0.66, p=0.0004, r2=0.436).  
    Methodology to quantify residue on FEES is sorely needed. This pilot study 
documented several novel methods to quantify residue on FEES: a computerized outline 
x x 10 
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providing a raw two-dimensional percentage of the space filled and a scaled amount to 
adjust for the size of the valleculae. The correlations between the two measures on the 
MBS and FEES images maintained moderate and significant correlations, supporting 
these preliminary methods to quantify residue on FEES. It appears as if scaling is an 
important aspect of measuring residue, to account for the size of the person, the size of 
the pharynx and anatomical cavities, or both. There are no other published studies that 
have attempted to use a computerized program to scale residue on FEES, precluding a 
discussion of how this study fits in with the literature. The study does, however, push the 
field forward to encourage use of novel technological applications to address the dilemma 
of measuring residue on FEES.  
 Many sources of variability were present in this pilot study and are limitations to 
the results. For instance, it is unclear how much of the pharyngeal cavity should be 
outlined to represent the housing. Another factor is that these measures were taken on still 
images and do not adequately represent the fluidity of residue as the patient breathes, 
moves, and performs clearing swallows. It would be of value to continue this study to 
determine the validity and reliability of the computerized methods, as well looking to 
other novel applications of measure residue on FEES. 
 
6.3. Conclusion 
 In conclusion, this body of work documents the past, present, and future 
directions for the problem in the field of deglutology with measuring pharyngeal residue 
on FEES. In Chapter 1, a concept map was proposed to more fully develop the idea of 
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how residue has wide-reaching implications in people with dysphagia. Chapter 2 listed a 
review of what the literature has documented thus far regarding types of measurement 
scales. Videofluoroscopy methods have taken on quantified and computerized 
measurement of residue, but there has been no work to quantify residue on FEES. 
Chapter 3 described the specific methods and the three research questions of the 
dissertation. The particular aims of this project were to compare visual analog scale 
ratings to categorical ratings of residue on FEES. The results and discussion in Chapters 
4 and 5 are intriguing and novel contributions to the field given the dearth of research 
regarding measurement of pharyngeal residue on FEES. In summary: 
• Clinicians are reliable in rating overall amount of residue. Both between- and 
within-rater reliability met acceptable levels of agreement, although within-rater 
reliability on VAS ratings were slightly higher than categorical ratings. This 
results hints towards the precision that clinicians desire when estimating amount. 
The precision is an important factor that is not embedded within categorical 
ratings. For this reason, if optimal reliability is a desired feature, then VAS ratings 
should be used instead of categorical ratings of residue.  
• In comparing clinicians, the experts’ ratings were not significantly different from 
other clinicians’ rating for any severity of any of the 3 boluses. Therefore, expert 
ratings are not unique but rather in line with the typical clinician. An average of 
clinician ratings would be the best reference standard until better methods are 
developed. 
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• Perceptual judgments of residue appear to reflect unequal intervals, an important 
concept that should be a consideration in future scales moving forward. This 
result suggests that VAS is the best way to rate pharyngeal residue on FEES, as 
the size of intervals can be variable. In categorical ratings, estimates are restricted 
within boundaries, which precludes precision when rating residue. 
• The clusters of ratings along the uneven spectrum of ratings support the already-
known increased risk of penetration and aspiration with increased residue amount. 
However, this study did not find any relationship between the residue ratings and 
measures of quality of life or diet. 
• Finally, a novel computerized method for rating residue was proposed as a two-
dimensional estimate of how much residue is present. Clinician ratings were 
similar, but higher than the computerized values, perhaps because clinician 
estimates accounted for depth. The computerized method is a valuable 
springboard for measuring the amount of residue in the pharynx. 
 
 It seems as if the research in this particular area of deglutology has been stalled 
due to measurement problems, which are a formidable challenge. This dissertation 
attempted to “measure what is not measureable” to assist in improving the measurement 
tools of residue.  
 There are countless challenges and assumptions associated with establishing an 
ideal evaluation method for residue on FEES. An ideal method would have:  
 1) Precision to accurately identify how much residue is present,  
 2) Established validity such that the measurement correlates strongly with the            
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     various facets of a swallowing problem including underlying pathophysiology    
     and clinical prognostic factors,  
 3) Established reliability for consistency between and within raters, and 
 4) Ease of use for clinical and research purposes.  
 
 The evolution of science must be timely and urgent and change with technology. 
In sum, the results of this dissertation suggest that a scale with unequal intervals and 
novel cut points of significance will be useful building blocks for future research. It is 
hoped that with better measurement will come better understanding of residue, its risks, 
and consequences.
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Beth Israel Deaconess Medical Center, Boston, MA     June 23, 2015 
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 • Presentation to clinical staff entitled “Non-Invasive Brain Stimulation  
    for Dysphagia: Clinical and Research Perspectives” 
 
Languages 
• English 
• Spanish 
• SAS (Statistical Analysis System) coding, up to the most recent version 9.4 
 
Teaching Experience in Higher-Level Education 
Lecturer at the Langmore FEES Foundation Course© 2012 – present 
 • Lecture: “Clinician Differences in Rating Residue: A Diagnostic Dilemma”  
    given at each course (4 times per year) 
 • Clinician mentor for participants, instructed clinicians in proper passing  
    techniques (Oct 2014) 
 • Mentored students at each course in cleaning procedures and FEES  
    hands-on practice 
 
Co-instructor of graduate courses,  
Sargent College, Boston University, Boston, MA    
 • Motor Speech (721 level), co-instructor Fall 2013, Fall 2014, Fall 2015 
  In this course, students reviewed the neuroanatomy underlying motor  
  speech disorders and learned about each type of motor speech disorder in 
  detail including apraxia of speech. Clinical assessment protocols were  
  learned and treatment interventions were covered.  
 • Acquired Cognitive Disorders (738 level), teaching assistant Spring 2014 
  This course provided an introduction to the rehabilitation of individuals  
  with acquired brain injury across the recovery continuum from acute care  
  to post-acute rehabilitation and reintegration into the community.  
  Students were taught the knowledge and skills required for diagnosis and  
  treatment of this population. Formal and informal assessment tools, treatment   
  paradigms, function of the interdisciplinary team, prevention, advocacy,  
  and strategies to address the needs of family members were presented. 
 • Advanced Dysphagia (739 level), co-instructor Fall 2013, Fall 2014, Fall 2015 
  This course dove more deeply into topics of importance to clinical practice 
  in dysphagia in a seminar format. Topics included evaluation procedures, 
  analysis of FEES and MBS studies, efficacy of novel and established  
  treatments, difficult decision-making, dysphagia in head and neck cancer, 
  neurologic disorders, and dementia. Lab sessions with hands-on scoping 
  were given.  
 • Dysphagia (738 level), co-instructor Spring 2014 
  This course provided basic information necessary to understand normal 
  and abnormal swallowing. Topics included neuroanatomy and physiology 
  of swallowing, clinical evaluations, instrumental evaluations (fluoroscopy 
  and endoscopy), etiology of dysphagia, treatment, swallowing disorders in 
  children, and complications of dysphagia such as quality of life outcomes 
  and co-morbidities.  
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Professional Experience 
Speech Language Pathologist Spring 2016 – present 
Department of Otolaryngology, Center for Voice and Swallowing 
 Boston Medical Center, Boston, MA                          
  • Certified by the Commonwealth of Massachusetts  
    Division of Professional Licensure, license number 9830, 
    serial number 551550, expiration date 1/6/18 
  • Conducted evaluation procedures to assess dysphagia 
     and voice issues via endoscopy, FEES, MBS, and  
     swallowing evaluations in acute and outpatient settings 
  • Evaluated and provided treatment for cognitive-linguistic 
     issues for inpatient and outpatient populations 
  • Counseled, evaluated, and treated head-neck cancer   
     patients throughout various stages of care (pre, during, 
     and post medical treatment) including alaryngeal  
       evaluation and assessment  
 
 Clinical Fellow, Boston Medical Center, Boston, MA Spring 2014 – Spring 2016 
  • Completed 1,260 hours of supervised clinical practice 
  • Mentored by Susan Langmore, Michael Walsh and Meredith Bosley 
 
Kindergarten Teacher, Carlsbad Montessori School, Carlsbad, CA 2008 – 2009   
  • Developed curriculum for math, science, reading,  
    writing, and social studies 
  • Established literacy program focusing on phonics,  
    comprehension, and decoding 
First Grade Teacher, PS 89 Elmhurst School, Queens, NY  2006 – 2008 
  • Instructed within the Dual Language Program, English/Spanish 
  • Specialized in Teaching English as a Second or Other Language   
     (TESOL) 
  • Trained in Wilson Fundations© 
  • Trained in Teacher’s College Reading and Writing Workshop Model© 
 
Clinical Internships 
Tufts Medical Center, Boston, MA                                                           Spring 2013 
 Experience: Adult and pediatric voice evaluations and treatment 
 (evaluated and treated patients in aspects of voice including reflux, 
 muscle tension dysphonia, subepithelial lesions, PVFM, irritable 
 larynx, cough suppression, and vocal hygiene) 
 
Bowman Elementary School, Lexington, MA                     Fall 2012 
 Experience: School-age language disorders (evaluated and 
 treated language, social, and pragmatic disorders in both a push-in 
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 and pull-out model in the public school setting with children aged 
 4–10) 
 
Boston University Clinic, Boston, MA                         Fall 2012 
 Experience: Diagnostic evaluations (completed formal testing  
 to evaluate speech and language disorders in one adult and two 
 children) 
 
Boston Medical Center (Acute Care), Boston, MA                        Summer 2012 
 Experience: Adult and pediatric speech and swallow evaluations and 
 treatment (evaluated and treated swallowing, cognitive, and speech 
 disorders in patients in the acute care setting) 
 
Boston University Clinic, Boston, MA                      Spring 2012 
 Experience: Adult aphasia therapy (Completed formal and informal 
 testing, designed and executed a treatment plan and activities to 
 remediate language deficits.) 
 
Baldwin Early Learning Center, Brighton, MA                    Spring 2012 
 Experience: Literacy intervention (Designed and executed lesson 
 plans and activities addressing the individual goals of elementary 
 school children within groups of 3–4 children.) 
 
Various Boston Public Schools, Boston, MA                         Spring 2012 
 Experience: Hearing practicum (Performed tympanometry, 
 otoscopy, and hearing screening on children aged 4–12.) 
 
Mentoring 
Student 
Time 
Frame 
Activities Previous status Current status 
Alix 
Rubio 
Spring, 
Summer 
2015, 
2016–2017 
• Patient enrollment 
• Video editing 
• Study planning 
Undergrad looking 
at possible career 
paths 
Full-time 
volunteer in 
Langmore Lab, 
SLP major 
Sky 
Yang 
Summer 
2014 
• Designed research studies 
• Completed IRB approvals 
across 2 campuses 
• Composing and submitting 
manuscripts 
Masters student SLP clinician in 
California 
Brittany 
Peterson 
Summer, 
Fall 2014 
• Mentored in choosing the 
best area of SLP 
• Designed research studies 
• Completed IRB approvals 
across 2 campuses 
• Composing and submitting 
manuscripts 
Masters student SLP clinician in 
Boston 
Audrey 
Purcell 
Summer 
2014 
• Designed research studies 
• Completed IRB approvals 
Masters student SLP clinician in 
Boston 
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across 2 campuses 
• Composing and submitting 
manuscripts 
Victoria 
Regan 
Summer 
2014 
• Designed research studies 
• Completed IRB approvals 
across 2 campuses 
• Composing and submitting 
manuscripts 
Masters student SLP clinician  
Marina 
Fagone 
Summer 
2015 
• Planning Dysphagia 
Awareness Week 
• Investigating prospective 
study sites 
Undergrad at 
Loyolla (SLP major) 
Undergrad at 
Loyolla (SLP 
major) 
Elizabeth 
Schrimpf 
Summer 
2015 
• Patient communication 
• Data entry 
• Planning Dysphagia 
Awareness Week 
College grad 
looking at SLP 
schools 
Enrolled in BU 
Masters program 
for SLP 
 
 
Advanced Training and Certification 
Certified in Flexible Endoscopic Evaluation of Swallowing (FEES) 2012 – present 
 • Successfully obtained course certificate (taught by Dr. Susan Langmore)  
 • Observed and approved by Dr. Gregory Grillone, Director of Otolaryngology 
 • Presently using FEES as a diagnostic and therapeutic tool with both  
    inpatients and outpatients 
 
Certified LSVT LOUD clinician                    July 2014 – present  
 • Attended 2-day workshop in New York City in July 2014 
 • Received 100% on qualifying exam to receive certification 
 • Certified to identify, assess, and treat dysarthria using LSVT LOUD 
 
Teaching Licensure for the                                                                   July 2013 – present 
Massachusetts Department of Elementary & Secondary Education  
 • Speech Language and Hearing Disorders, All Levels 
 • MEPID:  53460866 
 
Emergency Medical Technician                      2011 
 • Certified as an Emergency Medical Technician by the National Registry 
 
Preliminary Multiple Subject Teaching Credential         2010 
 • Authorized within the county of San Diego to teach all subjects  
   grades twelve and below, including preschool, and to teach classes  
   organized primarily for adults. 
 
Professional Public School Teacher Certificate                                             2010 
 • Awarded by State of New York Education Department after  
   three years of full-time teaching and professional development 
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Lead Teacher for Dual Language Program, PS 89, Elmhurst, NY       2008 
 • Named Lead Teacher for the first-grade Britton Academy 
                            
School Representative, PS 89, Elmhurst, NY          2008 
 • Selected by principal for school’s Quality Review performed by  
   New York City Department of Education             
 
Other Professional Activities 
American Speech-Language Hearing 2016     Winter 2015 – present 
Topic Committee Member  
 • Generate ideas for invited sessions 
 • Identify speakers and designate leads to develop sessions 
 • Review submitted abstracts 
 
Sargent College Research Symposium Committee Leader       2015 – 2016  
 • Provide academic service for the graduate program of Sargent College 
 • Coordinate and carry out guest lectures from across the US 
 • Host guest and facilitate lecturing 
 
Journal Reviewer               Summer 2015 – present  
 • Reviewer for:  
         Head and Neck (impact factor: 2.76), 
                    Dysphagia (impact factor: 2.03),  
                   Critical Care (impact factor: 2.19),  
                   Acta Neurologica Belgica (impact factor: 0.60) 
 • Communicate critiques of manuscripts with journal editor 
 
Graduate Tutor          Summer 2013, Winter 2015 
 • Helped a school teacher receive a degree in advanced reading instruction  
 
Evaluation Consultant, Bowman Elementary School, Lexington, MA         Fall 2013 
 • Conducted evaluations of school-age language disorders  
 • Wrote and submitted evaluation results to send to parents and IEP team 
 
Boston University Conference of Language Development        2011 – 2012 
 • Volunteer Chair, Boston, MA         
 
KIPP Academy, Lynn, MA                                 2009 – 2010 
 • Volunteer fifth grade reading teacher 
 • Class monitor and instructor of students in need of individualized instruction 
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Community Engagement 
Blogger for community outreach for swallowing problems June 2015 
 • http://www.dysphagiacafe.com/2015/07/22/inspiring-dysphagia-awareness/ 
 
Volunteer San Diego, San Diego, CA 2008 – 2011 
 
Goods for Good, Malawi, Africa Summer 2009  
 • Leader of volunteer group for St. Mary’s orphanage 
 • Eighth grade English tutor for St. Mathias Primary School  
 
Project SHINE, Utica, NY October 2006 – April 2006  
 • English instructor to adult refugees 
 
International Student Volunteers, Dominican Republic Summer 2005 
 • Community development participant and children’s program instructor  
 
Student Athletic Advisory Council Member, Hamilton College, NY 2004 – 2006 
 • Vice Chair, Academic Committee Chair (2005–2006) 
 • Official NESCAC representative (2005–2006) 
 
Drop Everything and Read (DEAR), Utica, NY 2002 – 2005 
 • Site coordinator and participant to second grade literacy program 
 • Leader who expanded the program to other schools 
